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ABSTRACT 
EFFECT OF pH AND TEMPERATURE ON THE BINDING INTERACTIONS 
OF CAFFEINE AND CHLOROGENIC ACID WITH SODIUM CASEINATE 
Emily S. Kong 
Coffee is a popular and well-loved beverage consumed worldwide by 
millions of people every day. While most patrons of coffee do so because of its 
unique and satisfying taste, consumers may be unaware of the potential beneficial 
health effects it also imparts. The antioxidants found in green coffee beans 
collectively known as chlorogenic acids (CGA) and caffeine are two of the most 
abundant bioactive compounds present in coffee. Both these bioactive compounds 
have been implicated in many studies to impart a wide range of health benefits, 
from reducing the risk of Type 2 diabetes, to their use as aides in weight 
management. Indeed, epidemiological studies on people who consume moderate 
amounts of coffee on a regular basis have unanimously shown benefits to overall 
health. 
While caffeine and CGA are naturally occurring compounds in coffee, 
their potential in conferring beneficial health effects warrant research into other 
potential food matrixes that can be used to bind and deliver these bioactive 
compounds into foods that do not naturally contain them. Milk proteins, 
specifically caseins, have been shown to be excellent vehicles to both bind and 
deliver sensitive bioactive compounds of various chemical and physical 
properties. Caseins have been shown in numerous studies to successfully bind to 
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molecules such as vitamin D2, ω-3 polyunsaturated fatty acids (DHA), and iron to 
name a few. Because caseins exhibit high versatility in binding a variety of 
molecules, caseins were the milk protein of choice for the experiments in this 
thesis. 
Polyphenols have been the subject of many studies on its binding capacity 
with milk proteins, but research on the binding capacity of caffeine with caseins is 
limited. Therefore, the objectives of this thesis are threefold: 1) develop, optimize 
and validate an HPLC method for the accurate and simultaneous determination of 
caffeine and CGA, 2) establish a procedure by which caffeine and CGA bind to 
sodium caseinate, and 3) determine the optimal treatment conditions of pH and 
temperature to increase binding interactions and speculate on the mechanism of 
binding for each bioactive compound. 
A reversed phase HPLC (RP-HPLC) method was developed and subjected 
to validation studies with good results in linearity (caffeine R2 = 0.9992, CGA  
R2 = 0.9995) and precision (RSD of caffeine <1%, RSD of CGA <2%). The 
developed method also demonstrated selectivity for caffeine and CGA. This 
method was then used to analyze sodium caseinate samples containing caffeine 
and 5-CGA. The results from these studies have shown that binding interactions 
between caffeine and sodium caseinate are temperature dependent (p < 0.01) 
whereas binding interactions between CGA and sodium caseinate are influenced 
by both pH and temperature (p < 0.01). Elucidating the binding mechanisms of 
caffeine and CGA to sodium caseinate and providing a sensitive analytical 
technique by which these compounds can be accurately quantified may facilitate 
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future research involving the use of caffeine and CGA in many other facets, as 
well as promoting its increased use in the dairy industry. 
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1.0 INTRODUCTION 
The major bioactive compounds of coffee have been studied extensively, 
with the first isolation of caffeine from green coffee beans performed in 1820 by 
the German chemist, Friedlieb Ferdinand Rung. Caffeine has been linked to 
reducing the risk of many metabolic diseases, including diabetes and certain 
cancers. In addition to caffeine, coffee is an abundant source of phenolic 
compounds, collectively known as chlorogenic acids (CGA) that have also been 
shown to impart many crucial health benefits. However, light and oxygen 
sensitivities of phenolic compounds, or antioxidants, makes transporting these 
compounds to be incorporated into different food matrixes a technical challenge. 
Caseins in milk have been reported to be excellent delivery systems via nano-
encapsulation because of their high tendency to aggregate into self-associated 
micelles, or by hydrophobic binding due to its unique amphipathic structure. The 
associative properties of αs1-, αs2-, and β-caseins via hydrophobic binding can be 
attributed mainly to the effect of temperature. 
Caseins have been specifically shown in previous studies to have excellent 
binding capacity with a wide variety of bioactive compounds including 
antioxidants, but literature on their binding capacity with caffeine is limited. The 
work herein attempts to elucidate the mechanism by which caffeine and CGA 
bind to casein micelles. First, a procedure will be established to bind these 
compounds to sodium caseinate. Using this procedure, we can then investigate 
what effects of pH and temperature are on the binding capacity of sodium 
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caseinate with these bioactive compounds. Secondly, determining the effects of 
pH and temperature will allow for speculation on sodium caseinate’s mechanism 
of binding. Heat treatment on caseins can lead to denaturation of the proteins, 
structural rearrangement, and other conformational changes within the protein 
which may increase the exposure and availability of hydrophobic sites for 
interaction with other compounds. Steric interactions and repulsive forces are 
mainly responsible for maintaining the structure of the micelle and preventing 
aggregation of the micelles. However, these interactions may also affect casein’s 
binding capacity with other compounds through electrostatic interactions resulting 
from changes in the ionic strength of the chemical environment. 
An analytical method to quantify these compounds by reversed phase 
HPLC (RP-HPLC) will be developed and validated in an effort to accurately 
characterize and quantify these compounds as well. 
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2.0  LITERATURE REVIEW 
2.1  Milk proteins 
The proteins in milk provide an extremely rich source of nutrition by 
acting as effective binding agents and delivery systems for sensitive bioactive 
compounds. Milk proteins are also extremely versatile due to its various 
functional, physiochemical, and structural properties. Briefly, a summary of the 
properties of milk proteins, with specific emphasis on caseins, is provided in the 
following sections.    
2.1.1 Overview of milk proteins 
Milk is a fluid secreted by all female mammalian species and is the 
primary source of meeting the nutritional needs for the neonate. Over time, milk 
proteins have been remarkable at adapting to their evolutionary task of delivering 
vital nutrients, the most important of which are amino acids: the building blocks 
of proteins, in addition to calcium and phosphates. As a dietary item, milk has a 
pleasant taste, flavor, and mouth-feel. In addition, milk is the single most 
complete food available. It comes as no surprise then, that the individual 
components in milk have been an attractive area of research, both industrially and 
academically.   
The composition of milk varies across species due to the unique 
nutritional and physiological requirements necessitated by that species (Table 
2.1). Bovine milk contains approximately 3.4% protein; of which approximately 
80% are caseins, and the remaining 20% are whey proteins, also known as serum 
proteins (Fox & McSweeney, 1998). The major role of caseins is to transport 
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calcium, essential amino acids, and antibodies, among other vital micronutrients, 
from the mother to the neonate. Therefore, caseins not only possess an important 
biological function, they are also a highly sought after functional food. Caseins 
are especially rich in essential amino acids; specifically αs2-caseins are rich in 
lysine, which plant based proteins are deficient. 
Table 2.1.  Composition % of milks of some species (Fox, 2003) 
Species Total Solids Fat Protein Lactose Ash 
Human 12.2 3.8 1.0 7.0 0.2 
Cow 12.7 3.7 3.4 4.8 0.7 
Goat 12.3 4.5 2.9 4.1 0.8 
Sheep 19.3 7.4 4.5 4.8 1.0 
Pig 18.8 6.8 4.8 5.5 -- 
Horse 11.2 1.9 2.5 6.2 0.5 
Donkey 11.7 1.4 2.0 7.4 0.5 
Reindeer 33.1 16.9 11.5 2.8 -- 
Domestic rabbit 32.8 18.3 11.9 2.1 1.8 
Bison 14.6 3.5 4.5 5.1 0.8 
Indian elephant 31.9 11.6 4.9 4.7 0.7 
Polar bear 47.6 33.1 10.9 0.3 1.4 
Grey seal 67.7 53.1 11.2 0.7 -- 
 
2.1.2 Functional milk proteins 
The principal functional food proteins derived from milk are caseins and 
whey proteins. The relative ease with which purified milk proteins can be 
obtained has caused an increase in market consumption as well as research into 
characterizing the properties of these proteins. Full characterization is required in 
order to understand and exploit the extensive applications of the functionalities of 
milk proteins. Because of its unique surface activities, caseins are the functional 
protein of choice for many food applications including their use as foaming 
agents, thickening agents, and for their stabilizing properties. Caseins also possess 
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a high water binding capacity, which is a desirable functional property for use in 
various foods, such as baked products and cheese products. Prior to their use in 
foods, caseins have historically been used for non-food applications such as 
adhesives for wood, plastics, paper coating and leather and synthetic fiber 
finishing. Caseins are composed of a hydrophobic and a hydrophilic region, 
making them distinctly amphipathic. Consequently, caseins readily absorb at air-
water and oil-water interfaces, giving them exceptional emulsifying properties 
(Fox & McSweeney, 1998). Furthermore, caseins can be obtained by other 
isolation and purification methods from skim milk to result in acid casein or 
rennet casein, by the addition of acid or the enzyme chymosin (also known as 
rennet), respectively. Caseins can further be processed and dried into caseinates 
with the addition of sodium hydroxide to yield sodium caseinate, and calcium 
hydroxide to yield calcium caseinate. The difference in the composition of each 
type of casein can be seen in Table 2.2.  
Table 2.2.  Composition of casein and caseinates (Southward, 1985) 
Component Acid casein Rennet 
casein 
Sodium 
caseinate 
Calcium 
caseinate 
Moisture (%) 11.4 11.4 3.8 3.8 
Protein (%) 85.4 79.9 91.4 91.2 
Ash (%) 1.8 7.8 3.6 3.8 
Lactose (%) 0.1 0.1 0.1 0.1 
Fat (%) 1.3 0.8 1.1 1.1 
Sodium (%) < 0.1 < 0.1 1.2 – 1.4 < 0.1 
Calcium (%) 4.6 – 5.4 7.3 – 7.7 6.5 – 6.9 6.8 – 7.0 
pH 4.3 – 4.6 6.5 – 6.7 6.5 – 6.9 6.8 – 7.0 
Solubility in 
water (%) 0 0 100 90 – 98 
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2.1.3 Whey proteins 
About 20–25% of the proteins in milk are whey proteins, also known as 
serum proteins. Whey proteins remain soluble at pH 4.6, the isoelectric point of 
caseins. The major fractions of whey are α-lactalbumin and β-lactoglobulin, 
representing approximately 20% and 50% of total bovine whey protein, 
respectively (Fox & McSweeney, 1998). A unique characteristic of α-lactalbumin 
is its biological role in the synthesis of lactose, interacting with UDP-galactosyl 
transferase to produce lactose from galactose (Brew, 2003). Other fractions of 
whey include immunoglobulins (Hurley, 2003), proteose-peptones (Rowland, 
1938) and lactoferrin, among other minor milk proteins that also play important 
biological roles (Lonnerdal, 2003).      
Whey proteins are used in a variety of food applications due to their 
unique functionality within a food system which include stabilization, gelation, 
and emulsification. Like caseins, whey proteins can be prepared from skim milk 
by using acid to yield acid whey, or by rennet to yield rennet (or sweet) whey. 
Further processing of whey by ultrafiltration, diafiltration or adsorption 
chromatography to remove lactose and salts results in the production of whey 
protein concentrates (WPC) containing 30–80% protein, and whey protein isolates 
(WPI) containing about 95% protein (Fox & McSweeney, 1998). Due to the 
ability to obtain such high-quality proteins, WPC and WPI are extensively used in 
the food industry for products such as muscle building and recovery protein 
drinks, in foods designed for weight management, and in prepared foods that 
provides high protein contents for extended satiety.   
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2.1.4 Milk proteins as delivery systems for bioactives 
Recently, interest in developing functional food systems that can also act 
as effective carriers and delivery systems of various bioactive molecules has 
gained much interest. Milk proteins contain chemical and structural versatility 
that make them ideal candidates for delivery of various bioactive molecules 
(Benshitrit et al., 2012). The ease with which milk proteins can be obtained by 
relatively inexpensive measures makes them a suitable target for use as a delivery 
system on an industrial basis. In addition, milk proteins are natural and are 
Generally Recognized As Safe (GRAS) for use in the food and pharmaceutical 
industry. Their unique surface properties allow them to deliver hydrophobic or 
hydrophilic bioactive molecules. They are able to form complexes with 
macromolecules and have innate protective qualities vital to delivering and 
improving the bioavailability of molecules prone to oxidation. Furthermore, milk 
proteins undergo extensive self-assembly and co-assembly; this causes the 
formation of micelles in caseins. Natural self-assembly is the basis for nano-
encapsulation of nutraceuticals (Semo et al., 2007) thus harnessing this property 
of milk proteins can prove instrumental for both the food and pharmaceutical 
industry. 
2.2  Caseins 
2.2.1 Chemistry of caseins 
About 95% of the casein in milk exists as colloidal molecules known as 
micelles that have a high tendency to aggregate; making them a very suitable 
vehicle for the delivery of bioactive molecules. Aggregation into large particles 
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that precipitate readily from solution occur at temperatures between 30–35 °C in 
acidic conditions. Casein micelles are responsible for the white color of milk due 
largely to their ability to scatter light. This white color is lost if the casein micelle 
structure is disrupted by removal of the inorganic constituents in casein, 
collectively known as colloidal calcium phosphate (CCP). Removal of the CCP 
results in a very different system from that of the normal milk system, namely the 
dissociation of the casein micelle structure.   
The pH of milk is approximately 6.7, at this pH casein micelles have a net 
negative charge and exists as a colloidal dispersion. Caseins are the insoluble 
proteins obtained by isoelectric precipitation of milk at pH 4.6. Casein can be 
obtained from milk by isoelectric precipitation or enzymatic (rennet) coagulation. 
This occurs after separation of the cream layer using centrifugation to produce 
milkfat products, such as butter and the phospholipid-rich milk fat globular 
membrane (MFGM). In isoelectric precipitation, the pH of skim milk is lowered 
from pH 6.7 to pH 4.6 at 20 °C to obtain a casein pellet after centrifugation. In the 
case of rennet coagulation, there is no change in the pH of milk, rather the 
enzyme rennet, also known as chymosin, is added. Chymosin cleaves a specific 
peptide bond  in the amino acid sequence of κ-casein, Phe105-Met106, to result in 
two fragments  known as glycomarcopeptide, and para-κ-casein. This cleavage 
has a specific consequence, causing κ-casein to lose its ability to stabilize the 
casein micelle, resulting in an increase in surface hydrophobicity and 
consequently the formation of a three-dimensional gel network or clot, in the 
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presence of calcium ions. This important reaction is essential in the cheese-
making process.  
In contrast to globular whey proteins, which are relatively hydrophilic, 
caseins have high surface hydrophobicity owing to the exposure of their 
hydrophobic residues and relative lack of secondary and tertiary structures. High 
levels of proline are responsible for the lack of α- and β-structures (Fox & 
McSweeney, 1998), necessary for formation of secondary and tertiary structures. 
As noted before, milk proteins are unique in their ability to bind and deliver 
hydrophobic or hydrophilic molecules. This notable feature can be explained by 
the uneven distribution of the hydrophobic and hydrophilic residues in the amino 
acid sequence, which gives caseins a distinctly amphipathic structure (Swaisgood, 
2003). Milk proteins can bind small hydrophobic molecules by means of several 
mechanisms, including: hydrophobic interactions, van der Waals attraction and 
hydrogen bonds (Livney, 2010).  
2.2.2 Physiochemical properties of the fractions of casein 
The composition of milk is well known and its individual constituents are 
well characterized. As such, it has been known that caseins are composed of four 
individual fractions: αs1-, αs2-, β-, and κ-caseins. κ-caseins play an extremely 
important physiological role in maintaining the integrity of the micelle structure 
by stabilizing the caseins in the presence of calcium ions in milk. Under a 
hypothesized model proposed by Holt (1994), κ-casein forms a “hairy layer” on 
the surface of micelles and is responsible for stabilizing the micelles sterically and 
electrostatically from aggregation. If this “hairy layer” is removed, via specific 
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hydrolysis or collapsed by ethanol, the colloidal stability of the casein micelle is 
compromised and results in precipitation of the casein (Holt and Horne, 1996).   
κ-caseins are the least sensitive to calcium salt and remain soluble under all 
conditions which would precipitate the other casein fractions. αs2-caseins are the 
most hydrophilic and most calcium sensitive of all the caseins, they precipitate at 
a Ca2+ concentration of less than 2 mM. αs1-caseins are slightly less sensitive to 
the presence of calcium salt, precipitating in the range of 3–8 mM Ca2+. β-caseins 
are the most hydrophobic fraction of the caseins and less sensitive yet to calcium 
salt, precipitating at a range of 8–15 mM Ca2+ at 37 °C (Swaisgood, 2003). Of all 
the casein fractions, β-casein is the most temperature sensitive. Monomers 
predominate in β-casein at low temperatures (<10–15 °C) but associate via 
hydrophobic bonding into micelles at increased temperatures (O’Connell, 2003). 
β-casein associates into soap-like micelles with a hydrophobic core and 
hydrophilic surface with increases in temperature, indicating that β-casein 
undergoes a temperature-induced micellization process. Being temperature 
dependent, this micellization process can be explained predominantly by 
hydrophobic bonding as the principal associative force, with electrostatic and 
steric interactions being responsible for maintaining the stability of the micelle 
and preventing the micelle from aggregating (O’Connell, 2003).  
Based on primary structures, αs1- and αs2-caseins are both suggested to be 
composed of a negatively charged N-terminal hydrophilic domain and a positively 
charged C-terminal hydrophobic domain. Interactions of the hydrophobic 
domains are likely to be responsible for the associative nature of the protein via 
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hydrophobic interactions. Consequently, the associative properties of both protein 
fractions are highly dependent on the ionic strength and temperature of its 
environment. It is important to note that association of these proteins may not 
only be due to hydrophobic interactions exclusively, as dissociation of the protein 
does not occur at low temperatures, as in the case of β-casein (Swaisgood, 2003). 
All casein fractions share in common a distinctly amphipathic structure which 
confers excellent surface properties.  
2.2.3 Structural properties of casein 
Many hypothesized models of the structure of casein have been 
developed, though a consensus within the scientific community regarding the 
presence or absence of secondary or tertiary structures of the casein micelle 
remains yet to be achieved. In an effort to validate a hypothesized model of the 
casein micelle, characterization of caseins using advanced imaging techniques 
have been at the forefront of native casein micelle research. These imagining 
techniques include, but are not limited to: confocal microscopy (CM), 
conventional electron microscopy, scanning electron microscopy (SEM), atomic 
force microscopy (AFM), cryo-transmission electron microscopy (cryo-TEM) and 
tomographic reconstruction models. Through the combined use of these 
techniques and years of research resulting in a wealth of new insights into the 
internal architecture of the casein micelle, certain structural and dynamic 
properties of the casein micelle can now be visualized and confirmed 
unequivocally. Work by Harte and coworkers (2011) demonstrated through the 
use of cryo-TEM that the interior of the casein micelle not only exhibited proteins 
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in a random arrangement, but that it also contained water-filled cavities and 
channels, as well as several hundred high-density nanoclusters (Figure 2.1). The 
presence of water-filled channels is not surprising, given that micelles are highly 
hydrated and bind approximately 2.0 g H2O/g protein (Fox, 2003). 
 
Figure 2.1.  Cryo-TEM tomograms of casein micelles (Trejo et al., 2011) A) 
Slabs (4.74 nm) through the centers of 2 micelles from the cryo-TEM tomograms; 
B) highlighting of the internal channels in the native casein micelles in the same 
image; C) highlighting of the internal cavities in the native casein micelles in the 
same image. Scale bar = 200 nm.  
2.3 Caseinates 
2.3.1 Preparation of sodium caseinate 
Several types of commercial caseinates are obtained from the 
resolubilization of the casein pellet remaining after isoelectric precipitation. 
Caseinates are produced by the addition of one of several dilute alkalis to adjust 
the pH of casein to 6.5–7.0 using sodium, potassium, ammonium, or calcium. The 
resulting homogenous solution is then spray dried to produce a caseinate powder 
(Fox & McSweeney, 1998). Sodium caseinate is the most common manufactured 
caseinate due to its high solubility in water and is therefore used in a wide variety 
of applications. Sodium caseinate has been exploited in many studies on its 
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binding and harnessing ability for the preparation of nano-vehicles for bioactive 
molecules because of its excellent solubility properties (Livney, 2010).   
2.3.2 Sodium caseinate as a delivery system 
Sodium caseinate has been established as an excellent vehicle for the 
transport of bioactive molecules and in the use as a delivery system through many 
previous studies. One such study by Singh and coworkers (2009) investigated 
sodium caseinate’s ability to bind to iron. Iron is an essential mineral, obtained 
only through diet, which aids in the production of hemoglobin present in red 
blood cells and is responsible for transporting oxygen and distributing it to cells 
throughout the body for metabolism. A lack of iron results in iron deficiency and 
anemia. The iron content in milk is approximately 0.2–0.5 mg/iron/L (Sugiarto, 
2009) and is considered too low as the recommended daily allowance (RDA) 
according to the Center for Disease Control and Prevention (CDC) is about 8 
mg/day in most adults; therefore fortification of milk and dairy products is 
necessary. Sodium caseinate and whey protein isolate (WPI) were used to 
determine the binding affinity of iron to those milk proteins. Their results showed 
that sodium caseinate contained more binding sites (n = 14) than WPI (n = 8) for 
binding iron, likely due to the presence of clusters of phosphoserine residues 
present in casein that are known to bind well to divalent cations (Sugiarto, 2009). 
The number of phosphoserine residues present in casein is different between the 
individual fractions of casein. αs1-casein contains the most residues and κ-casein 
containing the least, suggesting binding of iron occurs between the individual 
fractions, rather than the casein micelle as a whole. The discrepancy in binding 
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affinities between sodium caseinate and whey protein may be explained by the 
difference in their chemical structure. Whey proteins are large globular proteins 
with a relatively compact, rigid structure whereas caseins possess a more open 
and flexible structure owing to the relative lack of secondary and tertiary 
structures, which facilitates the binding of various bioactive molecules, including 
metal ions such as iron. It is important to note that binding affinity is a function of 
environmental conditions, such as pH and temperature; suggesting binding may 
be due to electrostatic, hydrophobic, or a combinatory effect of both interactions.  
Curcumin is a polyphenolic compound found in the spice turmeric, which 
has been implicated in decreasing the risk of Alzheimer’s disease in India, a 
country known to use and consume large amounts of turmeric in their traditional 
foods (Govindarajan, 1980). Curcumin has also been shown to possess anti-
cancer, anti-microbial, and anti-inflammatory properties in addition to its 
antioxidant activity (Maheshwari et al., 2006). However, the low solubility of 
curcumin in aqueous solutions remains a limitation in effectively delivering the 
bioactive compound to be metabolized. Binding curcumin to protein complexes, 
particularly water soluble milk proteins, and delivering the compound to the site 
where it can be metabolized may possibly mitigate this problem. Corredig and 
coworkers (2012) have shown that curcumin binds to nonpolar regions of the 
casein micelle, indicating that binding occurs mainly due to hydrophobic 
interactions.   
Sodium caseinate has also been shown to be effective carriers of many 
other bioactive compounds of various chemical properties, such as soy 
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phospholipids (Istarova, 2005), vitamin D2 (Semo et al., 2007), omega-3 
polyunsaturated fatty acids (Zimet et al., 2011), and gum arabic (Ye, 2012).     
2.4 Coffee 
2.4.1 History and background  
Coffee is a popular beverage consumed throughout the world from as far 
back as the tenth century, though it may have been cultivated in indigenous 
Ethiopia as early as 575 A.D. (Dews, 1984). According to historical records, the 
first reliable reference of a caffeine-containing beverage described in a Chinese 
dictionary is tea around 350 A.D., long before the first mention of coffee.  Coffee 
was consumed as a hot beverage around 1000 A.D. It has a pleasant taste, aroma 
and is consumed both for its flavor and stimulating effects of caffeine alike. It is a 
versatile food; its grounds can be incorporated into other foods, it can be 
sweetened and used in baked goods and of course, it can be brewed and consumed 
as a beverage. The majority of coffee beverage consumption is from the Coffea 
arabica (Arabica) and Coffea canephora (Robusta) species. Arabica coffee is 
considered to have a superior taste to Robusta coffee and is why it represents 
about 70% of the world market (Lean, 2012) and reaches higher prices in the 
international market (Gielissen & Graafland, 2009). Robusta beans on the other 
hand, are often used in instant coffees.  
Coffee consumption rates rose from 3.5 kg/person/year to 4.4 
kg/person/year in the United States from 1995 to 2007, and from 3.3 
kg/person/year to 4.1 kg/person/year in Europe (World Resources Institute, 2011). 
The desirable effect of caffeine is undoubtedly one of the major contributors to 
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this increase in coffee consumption. Coffee also contains many micronutrients, 
such as magnesium, potassium, niacin and vitamin E, all of which could 
contribute to the overall health benefits of coffee consumption (Higdon & Frei, 
2006). However, coffee is composed of over a thousand different compounds that 
contribute both to its taste and beneficial attributes, yet many of these compounds 
remain yet to be characterized. 
2.4.2 Composition of the coffee fruit 
The coffee fruit is composed of several layers that each have a distinct 
function in protecting the cherry at the center of the bean and are depicted in 
Figure 2.2. The coffee bean is composed of three distinct layers: a smooth but 
tough outer skin layer known as the pericarp, followed by a fibrous layer of sweet 
pulp, called the outer mesocarp, and finally a thin yellowish layer known as the 
endocarp or parchment. Between the mesocarp and endocarp layers lies a 
translucent, colorless and viscous layer of mucilage, also known as the pectin 
layer. The coffee cherry, or endosperm, is covered by a layer known as the 
silverskin (Belitz et al., 2009; Berbert et al., 2001). Upon ripening of the fruit, the 
pericarp changes colors ranging from yellow to red, depending on the specific 
genotype. The amount of caffeine found in the pericarp is approximately two to 
ten times lower than that of the amount found in the seed. This is primarily 
because caffeine is only synthesized in the earlier developmental stages of the 
seed and thus is not continually synthesized during fruit maturation (Esquivel & 
Jimenez, 2012). 
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Figure 2.2.  Layers in a coffee fruit (Esquivel & Jimenez, 2012). 
2.4.3 Processing & effects of roasting on coffee beans 
Green coffee beans can be processed by one of two methods, via dry or 
wet processing. Dry processing involves drying the coffee fruit in the sun before 
being mechanically hulled, removing the dried husks containing the skin, pulp, 
mucilage and parchment layers in addition to much of the silverskin in a single 
step. Wet processing is a much more involved process which includes separation 
of the ripe and unripe berries in water based on their density. The outer layers of 
the fruits are removed by pressing the fruit through a screen with water. The 
middle layers of the fruit are removed next through a fermentation step which 
hydrolyzes the mucilage layer using enzymes from within the coffee tissues as 
well as from microorganisms found on the skin of the fruit (Belitz et al, 2009; 
Vaast et al., 2006). The final hulling step removes the parchment layer from the 
beans after drying. An additional polishing step is optional to remove the 
silverskin layer. Though the multistep wet process method takes significantly 
more time and energy, it has been shown that this method yields higher contents 
Pericarp Pulp 
Mucilage 
Parchment Silverskin 
Bean 
 Page 18 
of CGA and trigonelline, and a lower content of sucrose in comparison to the dry 
method (Duarte et al., 2010).  
Sensory attributes of a coffee beverage such as flavor, aroma and body, 
are developed during the roasting process and due largely in part by the CGA 
content in the beans, which gives coffee its characteristic and desirable properties. 
Therefore, the amount of CGA is a large determinant of coffee cup quality. 
During processing and roasting, CGAs may be degraded into low molecular 
weight compounds through hydrolysis, thus dark roast coffee tends to contain a 
lower amount of CGAs compared to its unroasted or light roast counterpart (Farah 
& Donangelo, 2006). The sensory profile of roasted coffee is a result of Maillard 
reactions, a complex series of reactions that take place at high temperatures and 
occur in the presence of amino acids and reducing sugars. Because CGA 
contributes to the antioxidative properties of roasted coffee as well, it makes sense 
that higher temperature of roasting results in a reduction of total CGA content 
(Moon et al., 2009). Green coffee beans subjected to severe roasting conditions 
can result in up to 95% loss of CGA (Trugo & Macrae, 1984). 
However, studies have also shown that roasted coffee extract have 
antibacterial activity against several strains of enterobacteria (Almeida et al., 
2006) as well as microorganisms such as Staphylococcus aureus and 
Streptococcus mutans (Daglia et al., 2007; Dacarro et al., 1995). Further, 
consumption of roasted coffee beverages may increase populations of 
Bifidiobacterium spp., the beneficial strain of bacteria found in probiotics, which 
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indicates that coffee consumption may possibly have some prebiotic effects as 
well (Jaquet et al, 2009). 
2.4.4 Coffee bioactives 
Coffee has a complex chemical spectrum containing over a thousand 
compounds, many of which still remain unidentified and thus difficult to assess 
the possible health benefits or adverse effects upon consumption. Of the 
characterized compounds, coffee contains varying levels of caffeine depending on 
the type of bean, with Robusta beans containing significantly more caffeine than 
Arabica beans. Many consumers of coffee do so because of the stimulating effects 
and increased alertness imparted by caffeine, which accounts for 1 to 4% of the 
bean on dry basis, and has a half-life of about 5 hours in most adults (Lean, 2012). 
Green coffee beans also consist of many phenolic compounds which account for 
up to 14% on dry matter basis (Esquivel & Jimenez, 2012). These phenolic 
compounds are esters of trans-cinnamic acids and quinic acids. Esterification can 
occur at positions 3, 4, or 5 and results in several isomers of CGA. Other phenolic 
compounds found in green coffee beans are caffeic, ferulic and 
dimethoxycinnamic acids.  
Other bioactive compounds that have been reported in green coffee beans 
are cafestol and kahweol (Figure 2.3). These diterpenes have been implicated in 
both positive and negative health roles. They have been shown to increase total 
serum cholesterol levels (Farah & Donangelo, 2006) and production of low 
density lipoprotein cholesterol (LDL) (Higdon & Frei, 2006). However,  kahweol 
has also been identified as  having potential  anti-inflammatory effects (Cardenas 
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et al., 2011). In addition, cafestol shows anti-oxidative properties, based on 
decreased DNA damage to cells treated with the diterpene (Lee & Jeong, 2007).  
Diterpenes in coffee may also promote the elimination of carcinogens. However, 
as with all constituents of coffee, the concentration of these compounds varies 
greatly depending on the type of bean, roasting procedures and brewing method. 
Interestingly, these diterpenes have only been found in unfiltered coffee, such as 
coffee obtained from boiling or by using a French Press.   
 
 
 
Figure 2.3.  Chemical structures of cafestol and kahweol (Higdon & Frei, 2006) 
R = H: free diterpene; R = fatty acid: diterpene ester 
2.4.5 Caffeine 
The chemical name for caffeine is 1, 3, 7-trimethylxanthine (Figure 2.4) 
and is a purine alkaloid that is naturally occurring in coffee beans. Caffeine is 
essentially completely metabolized by the liver into its primary metabolite, 
paraxanthine, and is catabolized to form xanthine and theobromine. Physiological 
effects of caffeine include central nervous system stimulation, increased 
awareness and metabolic rate, increased concentration, and acute elevation of 
blood pressure, in addition to diuresis (Higdon & Frei, 2006). These effects can be 
felt relatively soon after ingestion. Caffeine is absorbed rapidly and almost 
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completely in the stomach and small intestine and distributed to all tissues, 
including the brain, which is likely why stimulation of the central nervous system 
occurs. Additional evidence on the stimulatory effects of caffeine is due to its 
antagonism of A1 and A2A subtypes of the adenosine receptors (James, 2004). 
Adenosine (Figure 2.4) is a constituent of adenosine triphosphate (ATP) and acts 
as an intermediary in a wide range of metabolic pathways, including behavioral 
influences of xanthines. The effects of adenosine are opposite that of caffeine, 
suggesting an antagonistic relationship and resulting in effects of caffeine that are 
generally stimulatory. This supports the hypothesis that xanthines act behaviorally 
by blocking adenosine receptors to elicit locomotive enhancement (Dews, 1984).       
As a natural product, caffeine has been used as a major ingredient in food 
products, including soft drinks, baked goods, dairy desserts, and candy, as well as 
an active ingredient in many pharmaceuticals. For instance, the use of caffeine in 
analgesics may be due to the fact that caffeine has been found to decrease the 
systemic elimination of acetaminophen and increase the bioavailability of aspirin 
(Higdon & Frei, 2006). The wide versatility of caffeine gives impetus to research 
investigating its use as an ingredient in foods, as well as into its metabolism and 
positive or adverse effects to health upon ingestion.     
 Figure 2.4.  Chemical structures of caffeine and adenosine
2.4.6 Chlorogenic acid (CGA)
Coffee is also an abundant source of 
commonly act as  antioxidants. Structurally, polyphenols are characterized by 
having one or more aromatic ring
Phenolic compounds are secondary metabolites that are ubiquitous const
involved in a higher plants defense mechanism against environmental stress. 
Conditions such as severe weather, excess ultraviolet (UV) or high visible light
and water stress can directly impact the amount of phenolic compounds produced 
by a plant (Farah & Donangelo
present in coffee beans thus varies
maturation, and are attributed to a lesser extent by agricultural practices 
1985).  
Present as a family of esters formed between 
quinic acid, the phenolic fraction of coffee is collectively known as chlorogenic 
acids (CGA). CGAs have been found on the surface within the cuticular wax and 
also in the cytoplasm of t
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antioxidants present in coffee which also include: caffeoylquinic acids (CQA), 
dicaffeoylqunic acids (diCQA), feruloylqunic acids (FQA), p-coumaroylquinic 
acids (pCoQA) and mixed diesters of caffeic and ferulic acids with quinic acid, 
each group containing at least three isomers. The nine main isomers of CGA are: 
5-CQA, 4-CQA and 3-CQA; 3,5-diCQA, 4,5-diCQA and 3,4-diCQA, 5-FQA, 4-
FQA and 3-FQA (Farah & Donangelo, 2006). CGA and its isomers make up the 
main components of the phenolic fraction of the unroasted, green coffee beans, 
reaching levels of up to 14% on dry matter basis (Farah & Donangelo, 2006). In 
green coffee beans, 5-CGA (Figure 2.5) alone accounts for about 56–62% of total 
CGA, with 4-CGA and 3-CGA isomers accounting for up to 10% each of total 
CGA (Farah & Donangelo, 2006). As such, esters of CGA are usually formed on 
carbon-5 of quinic acid but also on carbons-3 and 4, and less commonly on 
carbon-1. Roasting causes isomerization of CGA resulting in a substantial 
decrease in substitution at the carbon-5 position and an increased level of 
substitution at the carbon-3 and 4 positions. (Trugo & Macrae, 1984; Leloup et 
al., 1995, Farah et al., 2005). The processing conditions, such as temperature, as 
well as brewing conditions (water temperature, water to bean ratio) also has a 
marked effect on the amount of CGA that is extracted from the coffee bean.   
 Figure 2.5.  Chemical structure of 5
2.5 Health benefits of coffee bioactives
2.5.1 Health benefits of caffeine
Coffee consumption is undoubtedly made popular by the increased 
alertness and stimulating effects of caffeine. It is the beneficial health effects of 
coffee bioactive compounds that make 
functionality and the increase in awareness of health and nutrition of foods, it is 
imperative that these individual components be studied extensively for any 
beneficial as well as adverse effects
characterized and has been 
epidemiological studies being at the forefront of investigating the associations 
between caffeine and potential health benefits in those who consum
Some of the health benefits of caffeine include reduced risk of depression in 
women with a mean age of 63 years
2011) as well as reduced cognitive decline in older women. Caffeine in coffee has 
also been observed to be inversely associated with the risk of Parkinson’s disease 
in men in case-control studies 
failed to show a correlation between
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decreased risk of Parkinson’s disease. These results may be attributed to the 
modifying effect of estrogen replacement therapy inhibiting cytochrome 
CYP1A2, which is also responsible for caffeine metabolism (Pollock et al., 1999).  
2.5.2 Health benefits of chlorogenic acid 
CGAs have numerous beneficial health properties due to their potent 
antioxidant activity, some of which include hepatoprotective, hypoglycemic and 
antiviral activities in addition to cell vitality (Cheng, 2011). 
Epidemiological studies have suggested that the major phenolic 
compounds in coffee, caffeic acid (CA) and CGA, and regular coffee 
consumption have an inverse correlation with the incidence of Type 2 diabetes 
(Greenberg et al., 2005). One of the causative factors of Type 2 diabetes may be 
due to misfolding of human islet amyloid polypeptides (hIAPP). Huang and 
coworkers (2011) have investigated the inhibitory effects of caffeine, CA, and 
CGA on toxic aggregation of hIAPP. This study has immense implications since 
Type 2 diabetes constitutes 90–95% of diabetic patients worldwide (Clark et al., 
1987). These studies concluded that while caffeine appeared not to have a 
significant inhibitory effect on the formation of lineal hIAPP fibrils, when 
compared to the major polyphenolic compound ( - ) –epigallocatechin 2-gallate 
(EGCG) found in tea, CA and CGA did have a marked inhibitory effect as 
detected by tioflavin-T (ThT) fluorescent dye binding studies and TEM imaging 
of the aggregates (Figure 2.6). The concentration of the coffee bioactive 
compound to hIAPP was also observed to affect the extent of inhibition. Since 
these studies were conducted in vitro, many physiological events such as 
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metabolism of the coffee bioactives into their metabolites and varying 
concentrations of hIAPP present in the body, the data from these studies suggest 
that regular coffee consumption may inhibit hIAPP amyloid formation, thus 
lowering the risk of Type 2 diabetes. A significant inverse association between 
the risk of Type 2 diabetes and coffee consumption has also been observed in 
many other epidemiological studies (Salazar-Martinez et al., 2004, Rosengren et 
al., 2004).   
 
Figure 2.6.  TEM images of hIAPP co-incubated with different compounds 
(Cheng, 2011). (A) hIAPP; (B) 1:1 mixture of hIAPP and EGCG; (C, E, G) 
equimolar amounts of caffeine, CA, and CGA; (D, F, H) 5-fold molar excess of 
caffeine, CA, and CGA. 
Inflammation has long been associated with a plethora of cardiovascular 
diseases, which include atherosclerosis, cancer, obesity, and diabetes (Lai et al., 
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2012). Cardiovascular disease continues to be the leading cause of death in 
developed countries such as the United States. Environmental factors such as diet 
have an immense impact on general health, one of which is modulating 
inflammation. Inflammation is a response triggered by noxious stimuli caused by 
either physical or chemical trauma. Phenolic compounds such as CGA have been 
shown to attenuate inflammation and confer anti-inflammatory effects (Frost-
Meyer & Logomarsino, 2012). Since polyphenols are extensively metabolized in 
the body, consuming polyphenol-rich foods can help mitigate the effects of 
chronic inflammation and aid in the prevention of cardiovascular diseases. 
However, one main disadvantage of polyphenol consumption is their relatively 
low bioavailability in the body and thus remains a technological challenge. 
Developing functional foods that effectively carry and deliver polyphenols to the 
site where they can exert their antioxidant potential has gained considerable 
attention.    
2.6 Techniques of analysis 
Because of the large variation in the amount of bioactive compounds 
present in coffee beans, it is imperative to develop reliable and sensitive methods 
for establishing levels of these bioactive compounds. Given the discrepancy 
between results obtained by high resolution chromatographic methods and by less 
sophisticated methods, the need to continually develop and optimize sensitive 
methods of detection and quantification is of paramount importance. Many 
compounds in coffee remain uncharacterized due largely to lack of commercial 
standards and similarities of their chemical structures. Consequently, sensitive 
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methods for proper identification and quantification are in high demand. Briefly, a 
summary of common methods employed in the isolation, determination and 
quantification of the coffee bioactive compounds, caffeine and CGA, will be 
discussed below. Methods of protein determination will also be reviewed.  
2.6.1 High Pressure Liquid Chromatography (HPLC) 
Separation of compounds using HPLC is achieved by exploiting 
differences in polarity.  Typically, compounds are carried via an aqueous solution 
of low ionic strength and attached to a stationary phase. There are many 
chromatographic methods used for separating compounds including: normal 
phase, reversed phase, ion-exchange, size-exclusion or gel permeation, metal 
interaction, and affinity chromatography. In the most commonly used method, 
reversed phase HPLC (RP-HPLC), the stationary phase is a column composed of 
a matrix of polar silica gel substituted with nonpolar hydrocarbon chains (e.g. C8 
or C18 alkyl chains). Compounds are carried through the column using a polar 
mobile phase and elution is obtained by increasing the hydrophobicity of the 
mobile phase. Compounds are driven by hydrophobic interactions to adsorb to the 
stationary phase (Swadesh et al., 1993). The compound of interest, the analyte, is 
then eluted based on its polarity with the most polar compounds eluting first and 
the less polar compounds eluting last. Nonpolar compounds have an affinity to 
interact with the relatively nonpolar hydrocarbon chains attached to the stationary 
phase and are retained longer than more polar compounds. The dimensions of a 
column, length and diameter, as well as the particle size of the packing material 
have a large effect on separation and resolution of analyte peaks and on 
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equilibration time. Therefore, the analytical column often has an impact on the 
performance of a chromatographic method. 
Chromatographic conditions may employ the use of isocratic or gradient 
elution. In isocratic elution, a single mobile phase remains at a fixed concentration 
throughout the analysis. In gradient elution, several mobile phases of various 
ionic strengths are mixed together by a high pressure pump and the concentration 
of the mobile phases varies throughout the run.  Gradient elution is preferred over 
isocratic elution if determination of several analytes within a single sample is 
needed. 
There are several types of detectors used in HPLC analysis, each having 
the ability to detect different types of molecules.  UV-detectors are commonly 
used to detect an array of small organic molecules that possess a chromaphore, a 
part of their chemical structure that has the ability to absorb UV-light (e.g. 
conjugated double bonds or aromatic rings). RP-HPLC has also been extended for 
the analysis of macromolecules, such as proteins. A major limitation to UV-
detectors is being able to measure only at one specified wavelength. Hence if 
there are several analytes in a sample that absorb at different wavelengths, using a 
UV-detector would mean having to inject the sample multiple times at different 
wavelengths to completely analyze the sample. A solution to this problem is to 
use a photo-diode array (PDA) detector. PDA detectors are capable of analyzing a 
sample at multiple wavelengths, allowing one sample with multiple analytes to be 
analyzed at once, saving time and money. 
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Several methods exist for the simultaneous determination of purine 
alkaloids and polyphenols by HPLC (Samanidou et al., 2012, Ramalakshmi et al., 
2011, Trugo et al., 1991). More sophisticated and sensitive methods of analysis, 
such as tandem mass spectroscopy, have also been employed for the 
determination of polyphenols in green coffee beans (Alonso-Salces et al., 2009). 
Caffeine in various coffee brews have also been determined by a rapid method 
known as direct analysis in real time (DART) ion source coupled to high-
resolution time-of-flight mass spectrometry (TOFMS) (Danhelova, et al., 2012). 
This sensitive method is not only capable of detecting and quantifying caffeine, it 
is also able to detect other polar compounds isolated from Arabica and Robusta 
coffee brews, measured in both positive and negative ion modes (Figure 2.7). 
Rapid and powerful methods of analysis such as DART-TOFMS may be used in 
the future in assessing the authenticity of coffee. Selection of the method and 
technique depends on the level of sensitivity needed for an analysis, and the 
availability of the instruments. However, analytical methods are often compared 
to results obtained by HPLC (Trugo et al., 1991) due to the simplicity of sample 
preparation, accurate results, availability and affordability of the instrument, and 
relatively low level of training required to complete an analysis. 
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Figure 2.7.  DART-TOFMS spectra (Danhelova et al., 2012). (m/z 100–450) 
acquired in DART positive and negative ion modes of the extracts of roasted 
ground Arabica and Robusta coffee brew. 
2.6.2 Oxygen Radical Absorbance Capacity (ORAC) assay of antioxidants 
Antioxidants are an important class of compounds used as preservatives in 
foods. They are radical inhibitors that prevent the oxidation of foods by 
preventing unwanted radical reactions by reactive oxygen species (ROS). An 
excess of ROS in the body leads to cellular injury and damage to proteins, which 
in turn plays a role in the development of many diseases, such as diabetes, 
cardiovascular disease, and neurodegenerative diseases. Consumption of 
antioxidants from food sources is one way to decrease ROS-induced oxidative 
stress in the body. In order to evaluate whether a particular food is an adequate 
source of antioxidants, it is important to assess the antioxidant capacity of its 
extracts. A classical tool for measuring antioxidant capacity is the Oxygen 
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Radical Absorbance Capacity (ORAC) assay. The ORAC assay is capable of 
measuring the antioxidant capacity of biomolecules from a variety of samples, 
making it an extremely versatile assay. In addition to its versatility, the assay can 
be performed with relative ease. An ORAC assay kit obtained from Cell Biolabs, 
Inc. (San Diego, CA) is a fast and reliable kit for the direct measurement of the 
antioxidant capacity from various food extracts. Once the appropriate reagents are 
prepared, sample preparation in a multi-well microtiter plate is performed by 
adding the sample and a fluorescein solution to each well in a 1:6 ratio and 
incubating at 37 °C for 30 minutes. The fluorescein solution is a fluorescent probe 
which is oxidized by peroxyl radicals. A solution of free radical initiator is added 
to each well and mixed immediately prior to being placed in a microplate reader 
at 37 °C and analyzed with an excitation wavelength of 480 nm and emission 
wavelength of 520 nm (Figure 2.8). The free radical initiator produces the peroxyl 
radicals to quench the fluorescent probe over time. Therefore, the antioxidants 
present in the sample works to block the peroxyl radical oxidation of the 
fluorescent probe and the antioxidant capacity of the sample is measured by 
comparison with a standard curve of vitamin E, measured in TroloxTM equivalents 
(TE). Another advantage of the ORAC assay is its ability to combine both 
inhibition time and degree of inhibition into a single quantity, the only method 
thus far capable of providing these results (Ramalakshmi et al., 2011).  
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Figure 2.8.  ORAC assay principle. ORAC assay of a sample is calculated by 
subtracting the area under the curve (AUC) of the blank from the AUC of the 
sample to obtain the net AUC (Cell Biolabs, Inc.).  
2.6.3 Protein analysis 
Numerous methods for the quantification of protein have been developed. 
The Official Methods of Analysis of AOAC International include the Kjeldahl, 
Dumas, and infrared spectroscopy methods (AOAC, 2000). The Kjeldahl method 
(AOAC, 995.04), developed in 1883 by Johann Kjeldahl, involves digestion of 
protein with sulfuric acid and conversion of the protein nitrogen to ammonium 
sulfate by oxidation with potassium permanganate, neutralization of the digest, 
and finally titration to obtain the percent nitrogen. A conversion factor is then 
used to convert percent nitrogen to percent protein. Although the Kjeldahl method 
for protein analysis is an AOAC method and commonly used, it can be quite time 
consuming and requires the use of hazardous chemicals. An alternative to the 
Kjeldahl method is the Dumas method (AOAC, 992.23), developed in 1831 by 
Jean-Baptiste Dumas. Samples are weighed into a tin capsule and placed in a 
combustion reactor equipped with a built in gas-chromatograph (GC). The 
nitrogen released by the sample is then collected and measured directly by the 
GC. This automated process takes considerably less time to analyze samples, and 
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requires no hazardous chemicals. However, like the Kjeldahl method, the Dumas 
method measures total organic nitrogen and therefore does not distinguish 
between protein and non-protein nitrogen (NPN). Infrared spectroscopy is used to 
measure the absorption of radiation by peptide bonds to estimate the protein 
concentration in a food sample (AOAC, 997.06).  
Another alternative method for the quantification of protein in a sample is 
the Bicinchoninic acid (BCA) method. The BCA method exploits the ability of 
proteins to reduce Cu(II) to Cu(I) under alkaline conditions (Smith et al., 1985). A 
purple-colored product is obtained by the chelation of two molecules of BCA with 
one cuprous ion. The color formed is proportional to the protein concentration in a 
sample as measured by a spectrophotometer at 562 nm. The concentration of 
protein in a sample is then compared to a standard curve of known concentrations 
of a protein such as Bovine Serum Albumin (BSA). Therefore, the BCA assay is 
used as a colorimetric method for the determination and quantification of total 
protein in a sample. This is a simple and widely used, albeit time sensitive method 
of protein analysis.  
2.7 Justification for work 
Given the increase in coffee beverage consumption in addition to an 
increase in popularity of incorporating pure extracts of coffee bioactive 
compounds into a wide variety of food products, it is necessary, if not imperative 
to develop analytical methods using sophisticated instruments that are both fast 
and reliable. Rapid methods of analysis facilitates the use of these compounds in 
ways that may not have been previously possible, such as using milk proteins to  
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bind and deliver into different food matrixes. Limited research has been done on 
the binding capacity of sodium caseinate with the major alkaloid in coffee, 
caffeine. Given the numerous health benefits conferred by caffeine and regular 
consumption of caffeine and antioxidant containing beverages such as tea and 
coffee; much attention has been attracted to projects involving the use of both 
these compounds. However, incorporation of these compounds has proven a 
technical challenge due to their susceptibility to oxidation. Binding these 
compounds with a protective vehicle for transport; such as casein micelles in milk 
proteins, may mitigate this challenge.  
The objectives of this thesis are to first develop and validate an HPLC 
method for the accurate and simultaneous determination of caffeine and CGA in 
sodium caseinate samples. Next, is to establish a procedure by which caffeine and 
CGA can be bound to sodium caseinate and investigate the effects of pH and 
temperature on its binding capacity. And last is to, determine the conditions that 
result in increased binding interactions and estimate the binding capacity of 
sodium caseinate with these bioactive compounds and speculate on their binding 
mechanism. Knowledge gained from these studies could promote the use of milk 
proteins in even more functional ways by elucidating the mechanisms and 
conditions by which proteins bind with these compounds and how changes in the 
chemical environment can increase binding interactions. Moreover, these studies 
aim to promote the use of dairy proteins with the health promoting constituents of 
coffee and to provide a means by which accurate and reliable quantification of 
these compounds can be achieved. 
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3.0  MATERIALS AND METHODS 
3.1 Development of a method for the simultaneous determination of caffeine 
and CGA by reversed phase High Pressure Liquid Chromatography  
(RP-HPLC) 
3.1.1 HPLC Method optimization for the analysis of caffeine and CGA in 
green coffee extracts  
3.1.1.1 Mobile phase gradient 
Mobile Phase A (MPA) was prepared in a 90:10:0.1 (v/v/v) of MilliQ 
Nanopure water/acetonitrile/formic acid. MilliQ Nanopure water (900 mL) was 
transferred to a suitable media bottle and 1.0 mL of formic acid (97% ACS grade, 
Acros Organics) was added and mixed well. The solution was then filtered 
through a polyethersulfone (PES) membrane filter (Cat # 431118, 0.22 µm, 
Corning Inc.) under vacuum. Acetonitrile (100 mL) (HPLC grade, Fisher 
Scientific) was then added to the solution and mixed well. Mobile Phase B (MPB) 
was prepared in a 75:25:0.1 (v/v/v) of MilliQ Nanopure water/acetonitrile/formic 
acid. MilliQ Nanopure water (750 mL) was transferred to a suitable media bottle 
and 1.0 mL of formic acid (97% ACS grade, Acros Organics) was added and 
mixed well. The solution was then also filtered through a PES membrane filter 
(Cat # 431118, 0.22 µm, Corning Inc.) under vacuum. Acetonitrile (250 mL) was 
then added to the solution and mixed well. The HPLC unit used (Shimadzu 
Prominence, CBM-20A) was equipped with an autosampler (SIL-20A), column 
oven (CTO-20A), and a photo-diode array (PDA) detector (SPD-M20A). The 
column employed was a Shimadzu C18 reversed phase (RP) column (Shimadzu, 
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Japan) with dimensions 4.6 mm x 150 mm. A 50 µL aliquot of the sample was 
injected at a flow rate of 0.6 mL/min.  
Original chromatographic conditions employed for the determination of 
caffeine in green coffee extracts resulted in co-eluting peaks (Figure 3.1).  
 
Figure 3.1.  HPLC chromatogram of caffeine analysis (280 nm) from a green 
coffee extract diluted 1:50 with MPA.  
Adequate peak separation and resolution is essential for proper peak integration 
and thus obtaining accurate results. Adjusting the gradient profile, in combination 
with other adjustments to the chromatographic conditions, attempts to effectively 
separate the peak co-eluting with caffeine. The original parameters for gradient 
elution, gradient “A”, is depicted in Table 3.1. Table 3.2 shows gradient “B”, the 
first attempt at resolving the caffeine peak by increasing to 12% solvent B at  
t = 15 minutes, 80% solvent B at t = 35 minutes and finally 100% solvent B at  
t = 37 minutes. This is in contrast to a slow linear increase to 100% solvent B at  
t = 43 minutes in the original gradient parameters. Gradient “B” also shortens the 
total run time to 62 minutes. Gradients “C” and “D” (Table 3.3 and Table 3.4) 
were slight modifications of gradient “B” at t = 15 minutes, holding all other 
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conditions of the gradient profile the same. Gradient “E” (Table 3.5) employs the 
use of a step-gradient profile, increasing the percentage of solvent B quicker and 
held at 20% over a longer period of time. Table 3.6 shows the final gradient 
profile with a total run time of 60 minutes. Figure 3.2 shows all proposed gradient 
profiles in a graphical form. Mobile phase A was held at 100% for 3 minutes, and 
then changed by a linear gradient to 100% B over 30 minutes. The mobile phase 
was held at 100% B for 7 minutes, and a linear return to 100% A was made over 5 
minutes. The mobile phase was held at 100% A for 18 minutes for re-
equilibration of the column prior to injecting a new sample. The composition of 
MPA and MPB remained unchanged from the original chromatographic 
conditions. Determination of the optimal gradient elution profile will be discussed 
in the results & discussion section of this thesis.   
Table 3.1.  Time program of gradient “A”  
Time (min) % Solvent B 
0.01 0.0 
3.00 0.0 
43.00 100.0 
50.00 100.0 
60.00 0.0 
75.00 0.0 
76.00 End 
 
Table 3.2.  Time program of gradient “B” 
Time (min) % Solvent B 
0.01 0.0 
3.00 0.0 
15.00 12.0 
35.00 80.0 
37.00 100.0 
42.00 100.0 
47.00 0.0 
62.00 0.0 
63.00 End 
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Table 3.3.  Time program of gradient “C” 
Time (min) % Solvent B 
0.01 0.0 
3.00 0.0 
15.00 10.0 
35.00 80.0 
37.00 100.0 
42.00 100.0 
47.00 0.0 
62.00 0.0 
63.00 End 
 
Table 3.4.  Time program of gradient “D” 
Time (min) % Solvent B 
0.01 0.0 
3.00 0.0 
15.00 20.0 
35.00 80.0 
37.00 100.0 
42.00 100.0 
47.00 0.0 
62.00 0.0 
63.00 End 
 
Table 3.5.  Time program of gradient “E” 
Time (min) % Solvent B 
0.01 0.0 
3.00 0.0 
4.00 20.0 
15.00 20.0 
35.00 80.0 
37.00 100.0 
42.00 100.0 
47.00 0.0 
62.00 0.0 
63.00 End 
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Table 3.6.  Time program of final gradient profile 
Time (min) % Solvent B 
0.01 0 
3.00 0 
30.00 100 
37.00 100 
42.00 0 
59.00 0 
60.00 End 
 
 
Figure 3.2.  Gradient profiles for separation of caffeine by HPLC.  
3.1.1.2 Analytical column 
The original analytical column used for the analysis of caffeine and CGA 
in green coffee extracts was a Shimadzu C18 reversed phase (RP) column 
(Shimadzu, Japan) with dimensions 4.6 mm x 150 mm. Subsequent analyses 
using this column afforded poor peak separation, poor baseline resolution at 280 
nm and consequently, improper caffeine peak integration. To mitigate these issues 
resulting in inaccurate quantification of caffeine, an Alltech Platinum RP C18 
Extended Polar Selectivity (EPS) (Grace Davison Discovery Sciences) column 
with dimensions 4.6 mm x 250 mm and particle size of 5 µm (Figure 3.3) was 
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selected due to its increased polarity and length which is known to improve peak 
separation. Aliquots of 50 µL samples of green coffee extract diluted 1:400 with 
MPA were injected using the original analytical column and then with the new 
analytical column, holding all other chromatographic conditions constant. A 
comparison of the ability of the analytical columns to effectively separate, 
resolve, and result in proper peak integration was done visually by overlaying the 
chromatograms through the use of EZ-Start 7.3 Chromatography Software 
(Shimadzu, Japan). Justification of using the Alltech analytical column in place of 
the Shimadzu analytical column will be provided in the results & discussion 
section of this thesis.  
 
Figure 3.3.  HPLC analytical columns. Top = Shimadzu RP C18 column, 
dimensions 4.6 mm x 150 mm; bottom = Alltech Platinum RP C18 EPS column, 
dimensions 4.6 mm x 250 mm.  
3.1.1.3 Column temperature 
The column oven temperature in the original chromatographic conditions 
was set at 40 °C. As part of further optimizing peak separation, column oven 
temperature was investigated in the range of 35 °C, 40 °C, 45 °C and 50 °C. A 
single sample of green coffee extract diluted 1:800 with MPA was injected at the 
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above temperatures using the new analytical column, holding all other 
chromatographic conditions constant. The samples were analyzed at both 280 nm 
and 330 nm for separation of caffeine and CGA across all temperatures. Peak 
separation was evaluated visually by overlaying the chromatograms using EZ-
Start 7.3 Chromatography Software (Shimadzu, Japan). Determination of the 
optimal column oven temperature will be discussed in the results & discussion 
section of this thesis.  
3.1.2 Development of a method for the simultaneous determination of 
caffeine and CGA in green coffee extracts by RP-HPLC 
The simultaneous determination of caffeine and 5-CGA was performed 
using reversed phase High Pressure Liquid Chromatography (RP-HPLC). The 
HPLC unit (Shimadzu Prominence, CBM-20A), depicted in Figure 3.4 was 
equipped with an autosampler (SIL-20A), column oven (CTO-20A), and a photo-
diode Array (PDA) detector (SPD-M20A). The column employed was a C18 EPS 
silica column with dimensions of 4.6 mm x 250 mm, and particle size of 5 µm 
(Grace Davison Discovery Sciences). A C18-EPS cartridge system guard column 
was also used containing the same packing material as the analytical column, with 
dimensions 7.5 mm x 3 mm (Grace Davison Discovery Sciences). Two mobile 
phases were mixed by a serial dual-piston pump (LC-20AT). The composition of 
MPA was 90:10:0.1 (v/v/v) MilliQ Nanopure water/acetonitrile/formic acid while 
the composition of MPB was 75:25:0.1 (v/v/v) MilliQ Nanopure 
water/acetonitrile/formic acid. The column was equilibrated at a column oven 
temperature of 40 °C in MPA for 15 minutes and at a flow rate of 0.60 
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mL/minute. 50 µL of the sample was injected and the mobile phase was held at 
100% A for 3 minutes, and then changed by a linear gradient to 100% B over 30 
minutes. The mobile phase was held at 100% B for 7 minutes, and a linear return 
to 100% A was made over 5 minutes. The mobile phase was held at 100% A for 
18 minutes for re-equilibration of the column prior to injecting a new sample. The 
total analysis run time was 60 minutes. The column was stored and washed in 
100% acetonitrile. Caffeine was analyzed at a wavelength of 280 nm while 5-
CGA was analyzed at a wavelength of 330 nm. Peak integration was performed 
using EZ-Start 7.3 Chromatography Software (Shimadzu, Japan). The developed 
analytical method was subsequently subjected to validation studies, discussed in 
the next section. 
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Figure 3.4.  Shimadzu Prominence HPLC unit. A) degassing unit (DGU-20A3); 
B) pumps (LC-20AT); C) autosampler (SIL-20A); D) communication bus module 
(CBM-20A); E) photo-diode array detector (SPD-M20A); F) column oven (CTO-
20A).  
3.2 HPLC Method validation studies 
3.2.1  Linearity 
Calibration curves of the analytes, caffeine and 5-CGA, were constructed 
using commercial standards purchased from Sigma Aldrich (St. Louis, MO). A  
1 mg/mL stock standard solution of each analyte was prepared in deionized (DI) 
water. The stock standard was then syringe filtered through a nylon filter (13 mm, 
0.45 µm, Fisher Scientific). Serial dilutions of each standard were prepared to 
obtain standard concentrations of 0.125, 0.0625, 0.0313, 0.0156, 0.00781 mg/mL. 
The standards were analyzed by RP-HPLC according to the newly developed 
analytical method mentioned previously. The peak areas were integrated using 
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EZ-Start 7.3 Chromatography Software (Shimadzu, Japan). A calibration curve 
was constructed by plotting the peak areas of each dilution of the standard against 
its known concentration in Excel 2010 (Microsoft).  
3.2.2 Precision 
Commercial standards of caffeine and 5-CGA were used to prepare a  
1 mg/mL stock standard solution. The stock standard was then syringe filtered 
through a nylon filter (13 mm, 0.45 µm, Fisher Scientific). Serial dilutions in DI 
water of each standard were prepared to obtain standard concentrations of 0.125, 
0.0625 and 0.0313 mg/mL. Each concentration of the caffeine and 5-CGA 
standards were injected five times, from five separate amber HPLC vials, on a 
single day to result in 15 total determinations for each analyte. The standards were 
analyzed by RP-HPLC according to the newly developed analytical method 
mentioned previously.  The peaks of each standard were integrated using EZ-Start 
7.3 Chromatography Software (Shimadzu, Japan) and the relative standard 
deviation (% RSD) of the peak areas were analyzed using Excel 2010 (Microsoft).     
3.2.3 Selectivity 
Preparation of a control sample containing all but the added bioactive 
compounds using the same sample procedure is necessary to establish selectivity 
of a method. A 3.4% (w/v) sodium caseinate control sample was prepared by 
dissolving 6.8 g of sodium caseinate (lot# ZC0027, 65% protein, Spectrum 
Chemicals) in 50 mL of DI water while vigorously stirring with a stir bar. The 
solution was allowed to stir for approximately 1 h, or until all the sodium 
caseinate had dissolved and resulted in a homogenous solution. An additional 50 
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mL of DI water was then added to result in a 3.4% (w/v) solution. Procedures for 
preparing sodium caseinate samples with caffeine and 5-CGA, outlined later, 
followed the above procedures, except the additional 50 mL of DI water was 
replaced with a 50 mL solution of caffeine or 5-CGA. Isoelectric precipitation of 
the sodium caseinate control sample was achieved by adjusting the pH of the 
sample to pH 4.6 using 0.1 N HCl (Fisher Scientific) at 30 °C. The sample was 
then centrifuged using an Eppendorf 5810 centrifuge (Hamburg, Germany) at 
3,000 rpm, 20 °C for 15 min. The sample supernatant was then syringe filtered 
through a nylon filter (13 mm, 0.45 µm, Fisher Scientific) and analyzed by RP-
HPLC according to the newly developed analytical method mentioned previously. 
3.3 Binding interactions of caffeine and 5-CGA with sodium caseinate 
3.3.1 Establishing a procedure for binding caffeine to sodium caseinate 
Given the limited research on the binding of caffeine and CGA to sodium 
caseinate, it was necessary to establish a protocol in order to carry out any further 
experiments. A procedure was established to bind caffeine and 5-CGA to sodium 
caseinate according to the methodology described by Zimet et al., (2011) with a 
few modifications. The molar ratio of sodium caseinate to caffeine was 1:1 and 
the molar ratio of sodium caseinate to 5-CGA was also 1:1. 
3.3.1.1 Preparation of caffeine stock standard 
A 0.264 mg/mL (1.36 x 10-3 M) caffeine standard (lot#BCBF3955V, 
HPLC grade, Sigma Aldrich) was prepared in a volumetric flask dissolved in and 
diluted to volume with DI water. The same lot of caffeine standard was used 
throughout all experiments to reduce variations in the response.  
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3.3.1.2 Preparation of sodium caseinate sample 
A 6.8% (w/v) solution of sodium caseinate (lot# ZC0027, 65% protein, 
Spectrum Chemicals) was prepared by slowly adding approximately 34 g of 
sodium caseinate to a beaker containing 500 mL of DI water while vigorously 
stirring with a stir bar to create a vortex. This procedure was found to be more 
effective at dissolving the caseinate powder without adhering to the sides of the 
beaker. The solution was allowed to stir for approximately 1 h, or until 
completely dissolved. Then 50 mL aliquots of the sodium caseinate solution was 
transferred into separate beakers and the combination of the treatment factors pH 
(4.4, 6.7) and temperature (25 °C, 72 °C) were applied. Samples treated at 25 °C 
were left at room temperature whereas samples treated at 72 °C were heated on a 
hot plate. The pH of the samples was then adjusted to pH 4.4 or 6.7 using 0.1 N 
HCl (Fisher Scientific) or 0.1 N NaOH (Fisher Scientific). All subsequent 
experiments were performed using the same batch of sodium caseinate to reduce 
variations in the response. These procedures were also followed for experiments 
using 5-CGA.      
3.3.1.3 Preparation of 1:1 M ratio sodium caseinate to caffeine 
samples  
Caffeine stock standard solution (50 mL) was slowly added dropwise to a 
50 mL aliquot of the homogenous 6.8% (w/v) sodium caseinate solution applied 
with the treatments mentioned above while stirring to prepare a 3.4% (w/v) 
caseinate sample with caffeine. The resulting sample had a final molar ratio of 1:1 
sodium caseinate:caffeine. A control sample of 3.4% (w/v) sodium caseinate was 
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prepared by adding 50 mL of DI water to a 50 mL aliquot of the 6.8% (w/v) 
sodium caseinate solution in a separate beaker while stirring at room temperature. 
A caffeine control sample (0.132 mg/mL concentration) was also prepared by 
adding 50 mL of DI water to 50 mL of caffeine stock standard at room 
temperature. The samples were then allowed to stir for 1 h, with the temperature 
of the heated samples maintained between 65–75 °C. At the end of the hour, the 
pH of the samples were measured and recorded. All samples were prepared in 
duplicate. 
3.3.1.4 Analytical fractionation 
Isoelectric precipitation of the caseins in the samples was achieved by 
heating the samples prepared at 25 °C to 30–35 °C on a hot plate while stirring 
and slowly adjusting the pH to 4.6 using 0.1 N HCl or 0.1 N NaOH. Samples 
prepared at 72 °C were cooled to 30–35 °C, and then the pH of the samples were 
adjusted to pH 4.6 using 0.1 N HCl or 0.1 N NaOH. The entire  sample was then 
quantitatively transferred into suitable centrifuge bottles and centrifuged at 3,000 
rpm, 20 °C for 15 min to obtain a casein pellet. The volume of the resulting 
supernatant was measured. These procedures were also followed for experiments 
using 5-CGA. All samples were wrapped in foil to protect from light degradation. 
3.3.2 Establishing a procedure for binding 5-CGA to sodium caseinate 
3.3.2.1 Preparation of 5-CGA stock standard 
A 0.482 mg/mL 5-CGA (lot#SLBB6914V, >95% titration, Sigma Aldrich) 
standard was prepared in a volumetric flask dissolved in and diluted to volume with DI 
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water. The same lot of 5-CGA was used throughout all experiments to reduce 
variations in the response. 
3.3.2.2 Preparation of 1:1 M ratio sodium caseinate to 5-CGA 
samples 
5-CGA stock standard solution (50 mL) was added dropwise to a 50 mL  
aliquot of the homogenous 6.8% (w/v) sodium caseinate solution applied with the 
treatments mentioned previously while stirring to prepare a 3.4% (w/v) caseinate 
sample with 5-CGA. The resulting sample had a final molar ratio of 1:1 sodium 
caseinate:5-CGA. A control sample of 3.4% (w/v) sodium caseinate was prepared 
by adding 50 mL of DI water to 50 mL of the 6.8% (w/v) sodium caseinate 
solution in a separate beaker while stirring at room temperature. A 5-CGA control 
sample (0.241 mg/mL concentration) was also prepared by adding 50 mL of DI 
water to 50 mL of stock 5-CGA standard at room temperature. The sample was 
then allowed to stir for 1 h with the temperature of heated samples maintained 
between 65–75 °C. At the end of the hour the pH of the samples were measured 
and recorded. All samples were prepared in duplicate.  
3.3.2.3 Analytical fractionation 
Procedures for isoelectric precipitation of caseins in samples containing 5-
CGA followed the same methodology as described previously for isoelectric 
precipitation of caseins in samples containing caffeine, outlined above.   
3.4 Experimental design 
A Generalized Randomized Complete Block Design (GRCBD), blocked 
by day, was employed in a 22 full factorial design with two replicates per block. 
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The treatment factors were pH and temperature, each at two levels (Table 3.7). 
The experimental unit was a sample of a 1:1 M ratio of sodium caseinate to 
caffeine or 5-CGA. Treatments were randomly assigned to the experimental unit 
using Excel 2010 (Microsoft) (Table 3.8 & Table 3.9). All treatments were 
applied to aliquots of the 6.8% (w/v) sodium caseinate solution prior to adding 
any caffeine or 5-CGA. The response was the concentration of bioactive 
compound detected in the supernatant after centrifugation using HPLC. 
Table 3.7.  Levels of the treatment factors  
Treatment Levels 
pH 4.4, 6.7 
Temperature 25°C, 72°C 
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Table 3.8.  Randomization of treatments to experimental unit in caffeine samples 
Run Order pH Temperature ( °C) Block (Day) 
1 6.7 25 1 
2 6.7 25 1 
3 6.7 72 1 
4 4.4 25 1 
5 4.4 72 1 
6 4.4 72 1 
7 6.7 72 1 
8 4.4 25 1 
9 6.7 25 2 
10 4.4 72 2 
11 6.7 72 2 
12 4.4 25 2 
13 6.7 72 2 
14 6.7 25 2 
15 4.4 25 2 
16 4.4 72 2 
 
Table 3.9.  Randomization of treatments to experimental unit in 5-CGA samples 
Run Order pH Temperature ( °C) Block (Day) 
1 6.7 25 1 
2 6.7 72 1 
3 6.7 25 1 
4 4.4 72 1 
5 4.4 25 1 
6 4.4 25 1 
7 6.7 72 1 
8 4.4 72 1 
9 4.4 25 2 
10 6.7 25 2 
11 4.4 72 2 
12 6.7 72 2 
13 4.4 25 2 
14 6.7 72 2 
15 6.7 25 2 
16 4.4 72 2 
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3.5 Application of established protocol and optimal treatment conditions on 
green coffee extract 
A permeate extract of green coffee was obtained from the liquid extraction 
of Arabica green coffee beans from Brazil using water. The extract was passed 
through a filtration system equipped with a membrane filter with a 5,000 
molecular weight cut-off. Lastly, the extract was passed through an ultrafiltration 
system (GEA RT-12) using the maximum cross flow ratio setting to achieve a 
flow rate of ~20 L/min. A clear, yellow permeate was obtained and used as the 
green coffee extract for further experiments (Figure 3.5). A 6.8% (w/v) sodium 
caseinate solution (50 mL) was prepared as previously described and heated to 72 
°C on a hotplate while stirring. The pH of the solution was then adjusted to pH 
6.7 using 0.1 N HCl. Then 50 mL of the green coffee extract was then slowly 
added to the sodium caseinate solution dropwise while stirring. The sample was 
allowed to stir for 1 h with the temperature maintained between 65–75 °C. The 
beaker used to contain the sample was wrapped in foil to protect from light 
degradation. The sample was cooled to 30–35 °C before adding 0.1 N HCl to the 
isoelectric point (pH 4.6) while stirring. The entire contents of the sample were 
quantitatively transferred into a suitable centrifuge bottle and centrifuged at 3,000 
rpm, 20 °C for 15 min. The volume of the supernatant was measured using a 
graduated cylinder. The sample supernatant was retained for HPLC and BCA 
analysis. Each sample was syringe filtered through a nylon filter (13 mm, 0.45 
µm, Fisher Scientific) and transferred into amber HPLC vials for analysis. The 
sample was prepared in triplicate.     
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Figure 3.5.  Permeate of green coffee extract obtained after ultrafiltration.  
3.6 Statistical analysis 
A Generalized Randomized Complete Block Design (GRCBD) blocked by 
day was employed in a 22 full factorial design performed in duplicate. The 
treatment factors were pH (4.4, 6.7) and temperature (25 °C, 72 °C). The response 
was the concentration of caffeine or 5-CGA detected in the supernatant of 
samples using HPLC. All data analysis was carried out using the statistical 
software, JMP Pro 10 (SAS Institute Inc.) with significance at p < 0.01. 
3.7 HPLC analysis of caffeine and 5-CGA 
HPLC analysis of caffeine and 5-CGA was performed following the 
developed method outlined previously in this thesis. All samples were syringe 
filtered through a nylon filter (13 mm, 0.45 µm, Fisher Scientific) and a 1.0 mL 
aliquot was transferred into amber HPLC vials for analysis. Samples were 
analyzed in the randomized order previously determined for sample preparation 
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(see Tables 3.8 and 3.9). All samples were analyzed on the same day of 
preparation to minimize any degradation of the bioactive compound. Peak 
integration was performed using EZ-Start 7.3 Chromatography Software 
(Shimadzu, Japan). All data was collected and analyzed using Excel 2010 
(Microsoft). The concentration of caffeine and 5-CGA in the samples was 
calculated through the use of standard calibration curves of each compound 
prepared at known concentrations.  
3.8 BCA protein assay 
Bicinchoninic acid (BCA) analysis was performed following instructions 
provided by the Pierce BCATM Protein Assay Kit (No. 23227, Rockford, IL). A 
standard curve was prepared using Bovine Serum Albumin (BSA) (Product No. 
23209, 2 mg/mL concentration) standard in 0.9% saline and 0.05% sodium azide 
in the concentration range of 2.0–0.025 mg/mL in DI water. DI water was also 
used as the blank. The working reagent (WR) was prepared by mixing Reagent A 
(Product No. 23228, containing sodium carbonate, sodium bicarbonate, 
bicinchoninic acid and sodium tartrate in 0.1 M sodium hydroxide) with Reagent 
B (Product No. 1859078, containing 4% cupric sulfate) in a 50:1 ratio, 
respectively.  
Samples were randomly selected from each treatment combination of 
caffeine and 5-CGA with sodium caseinate samples for BCA analysis (Table 
3.10), along with the sodium caseinate solution (6.8% (w/v)) and sodium 
caseinate control (3.4% (w/v)) containing neither caffeine nor 5-CGA. The 
sodium caseinate solution was diluted three times (1:25, 1:50 and 1:100) using DI 
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water to ensure a measurable absorbance was obtained. All other samples were 
analyzed without any further dilution. A 1:20 sample:WR ratio was used for the 
preparation of BCA samples. 2.0 mL of WR was added into separate 15 mL 
Falcon tubes. An aliquot of 100 µL of each standard and sample was then added 
separately to the tubes, capped and mixed well. The samples were incubated at  
37 °C for 30 minutes, cooled to room temperature, and measured using a 
SpectraMax Plus spectrophotometer (Sunnyvale, CA) at 562 nm within 10 
minutes. All samples were analyzed in duplicate. The absorbance of the blank 
solution was subtracted from the absorbance of each standard and sample prior to 
analyzing the data in Excel 2010 (Microsoft). 
Table 3.10.  Randomly selected samples and their treatment combinations 
Sample pH Temperature ( °C) 
Sodium caseinate & 
caffeine 
6.7 25 
6.7 72 
4.4 25 
4.4 72 
Sodium caseinate &  
5-CGA 
6.7 25 
6.7 72 
4.4 25 
4.4 72 
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4.0  RESULTS AND DISCUSSION 
4.1 Development of a method for the simultaneous determination of caffeine 
and CGA in green coffee extracts by RP-HPLC 
4.1.1 Determination of HPLC chromatographic conditions 
The principal objective of these experiments was to develop an HPLC 
method for the quantification of caffeine and 5-CGA in green coffee extracts. 
Eventually, this method would be extended to sodium caseinate samples 
containing both these analytes. Caffeine and 5-CGA are both of relatively low 
molecular weights (< 2000) and are both soluble in the mobile phases employed 
indicating that RP-HPLC is a suitable choice for quantification. Three main 
parameters of the chromatographic conditions evaluated for optimization were: 
gradient profile, analytical column, and column temperature. Optimization within 
each of these conditions resulted in the final developed RP-HPLC method.  
4.1.1.1 Gradient profile 
Four variations of the original gradient profile were evaluated for the 
purpose of separating caffeine and its co-eluting peak, in addition to reducing 
total run time. While only changing the gradient profile did not result in 
successful separation of the caffeine peak, the total run time was decreased from 
72 min to 60 min (Figure 4.1). Eluent strength decreases with an increase in 
polarity of the mobile phase. Thus the reduction in time to reach 100% solvent B 
in the final gradient profile provided better separation of the caffeine and co-
eluting peak when combined with optimization to the column and column 
temperature. In addition, a closer inspection of Figure 4.1 shows a slight increase 
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in peak sharpness was observed in the final gradient profile when compared to the 
original (Figure 4.2). The other variations of the gradient profiles B–E resulted in 
only slight changes from the original gradient profile (chromatograms not shown).  
 
Figure 4.1.  Overlay of green coffee extract. Sample diluted 1:50 with MPA 
analyzed at 280 nm. The blue trace is the original gradient profile with total run 
time 72 min, the green trace is the new gradient profile with total run time 60 min.  
 
Figure 4.2.  Slight peak sharpening observed in caffeine peak using new gradient 
profile (green trace) vs. old gradient profile (blue trace).  
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4.1.1.2 Analytical column 
The next parameter evaluated was the analytical column. The packing 
material in both columns was composed of a bonded silica surface covalently 
attached with octadecyl (C18) chains, resulting in a nonpolar stationary phase. A 
nonpolar stationary phase used in RP-HPLC concurrent with gradient elution 
provides rapid elution of polar compounds carried via a polar mobile phase and 
slower elution of nonpolar compounds that have a greater affinity to interact with 
the nonpolar bonded silica surface. Therefore, increasing the length of the 
nonpolar stationary phase results in enhanced separation of polar and nonpolar (or 
slightly less polar) compounds by increasing interactions sites available to the 
nonpolar analyte. An increase of just 100 mm of the column length from the 
Shimadzu C18 RP column (length 150 mm) to the Alltech Platinum C18 RP-EPS 
column (length 250 mm), as well as the difference in packing material of the 
columns provided superior separation of the caffeine peak (Figure 4.3).  
Figure 4.3.  Overlay of green coffee extract (diluted 1:400 with MPA) using 
Shimadzu (green trace) and Alltech column (blue trace) for caffeine analysis.  
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4.1.1.3 Column temperature 
Control of column temperature in HPLC is essential for improved 
retention time reproducibility and precision of a quantitative analysis. Increases in 
column temperature provide a decrease in retention time and improves baseline 
resolution by accelerating diffusion of solutes. However, increases in column 
temperature generally also results in quicker degradation of the stationary phase 
thereby decreasing column lifetime. Therefore, it is imperative to determine the 
optimal column temperature for adequate elution and resolution of an analyte that 
will also result in greatest column lifetime. Four column temperatures: 35 °C,  
40 °C, 45 °C, and 50 °C were investigated in an attempt to optimize elution time 
of the caffeine and 5-CGA peaks concurrent with the optimized gradient profile 
and updated selection of the analytical column (Figure 4.4 & Figure 4.5).  
 
Figure 4.4.  Overlay of caffeine peak at 280 nm. From left to right: caffeine peak 
measured at 50 °C, 45 °C, 40 °C, and 35 °C.  
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Figure 4.5.  Overlay of 5-CGA peak at 330 nm. From left to right: CGA pkea 
measured at 50 °C, 45 °C, 40 °C, and 35 °C.   
Elution of the caffeine peak was observed to decrease from approximately 
RT = 27 min at 35 °C to approximately RT = 22 min at 50 °C, a total reduction of 
5 minutes in retention time. A slight general increase in peak sharpness and 
resolution was also observed with an increase in column temperature. In addition, 
improved peak separation was observed in an unknown peak containing a 
shoulder at approximately RT = 2.5 min at 50 °C compared with the same sample 
injected at 40 °C (Figure 4.6). However, as mentioned previously, there must be a 
balance between retention time and column lifetime. Therefore, column 
temperature at 40 °C was determined the optimal temperature that provided 
adequate peak elution and resolution without subjecting the column to severe 
degradation at the higher temperatures investigated.  
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Figure 4.6.  Separation of unknown peak with shoulder at 50°C (fully resolved) 
compared to 40°C (co-eluting) at 330 nm.  
4.2 HPLC Method Validation 
4.2.1 Linearity 
Linearity is the test of a method’s ability to quantitatively analyze a 
sample and obtain results that are directly proportional to a known concentration 
of the analyte within that sample. Many factors such as age of the detector, 
adsorption of the analyte to the surface of the sample vial, degradation of the 
sample upon sitting, and phase separation of the sample can lead to under or over 
estimation of the amount of the analyte in a sample and can result in nonlinear 
results. Therefore, the importance of verifying the linearity of a method is a 
crucial step in method development.  
The linearity study was carried out by preparing a stock caffeine and 5-
CGA standard solution of high concentration (1 mg/mL) and performing serial 
dilutions using a micropipette to a known concentration range resulting in five 
standards (Table 4.1). A graph of peak area vs. concentration was plotted and a 
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least squares fit regression line was constructed (Figure 4.7 and Figure 4.8). A 
correlation coefficient R2 ≥ 0.980 is considered an acceptable result for linearity. 
A correlation coefficient R2 < 0.980 indicates nonlinearity of the method. The R2 
value for caffeine and 5-CGA was 0.9992 and 0.9995, respectively. This 
demonstrates linearity of the developed RP-HPLC method.     
Table 4.1.  Concentration range and peak areas of caffeine and 5-CGA used in 
linearity study 
Dilution Concentration (mg/mL) 
Caffeine peak 
area 
5-CGA peak 
area 
1:8 0.125 21909584 27548226 
1:16 0.0625 11563744 13116460 
1:32 0.0313 5869057 6249741 
1:64 0.0156 2946908 2993404 
1:128 0.00781 1474020 1441236 
 
 
Figure 4.7.  Graph of caffeine peak area (mAU) vs. concentration (mg/mL) in 
linearity study. R2 = 0.9992. 
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Figure 4.8.  Graph of 5-CGA peak area (mAU) vs. concentration (mg/mL) in 
linearity study. R2 = 0.9995. 
4.2.2 Precision 
Precision is a measure of the closeness of agreement (degree of scatter) 
between a series of measurements of the same homogeneous sample analyzed at 
set chromatographic conditions. Intra-assay precision, or within-day precision, 
was evaluated for the precision study. Five separate injections of three standard 
concentrations of caffeine and 5-CGA were each measured within the same day 
(Figure 4.9). The relative standard deviation (% RSD) between the five injections 
of each standard concentration was calculated to determine the precision of the 
method. Acceptable precision ranges for HPLC methods are between <2–10%, 
with <2% RSD being a method with great precision, <5% RSD being a method 
with good precision, and <10% RSD being a method with tolerable precision. An 
RSD value >10% indicates a method with poor precision. The average RSD was 
<1% and <2% for caffeine and 5-CGA, respectively. These results indicate great 
precision of the developed method (Appendix A).    
0
5000000
10000000
15000000
20000000
25000000
30000000
0.000 0.050 0.100 0.150
5-
C
G
A
 
pe
a
k 
a
re
a
 a
t 3
30
 n
m
Concentration (mg/mL)
 Page 64 
Figure 4.9.  Overlay of caffeine standard at three concentrations. Five injections 
for each sample, RSD < 1% for all concentrations. Note chromatogram zoomed 
in to show time between 17–28 min only (total run time 60 min).  
4.2.3 Selectivity 
Selectivity of a method is the measure of a method’s ability to selectively 
detect the analyte from interferences present in the sample matrix. This is 
achieved through analyzing a sample containing the analyte and a sample 
containing only the sample matrix (the sample blank). A lack of response or 
detection in the sample matrix indicates a method’s selectivity for the analyte. A 
sample of 1:1 M ratio sodium caseinate:caffeine and 1:1 M ratio sodium 
caseinate:5-CGA was analyzed along with the sodium caseinate control sample 
(the sample blank) containing only the sample matrix. Selectivity of the method 
was determined through a visual comparison of the chromatograms. The method 
correctly identified and quantified caffeine (Figure 4.10) and 5-CGA (Figure 
4.11) in each sample but did not detect any peaks in the sample matrix at 280 nm 
or 330 nm (Figure 4.12 & Figure 4.13). This indicates the developed method is 
Minutes
17 18 19 20 21 22 23 24 25 26 27 28
m
Au
0
200
400
600
800
0
200
400
600
800
Ca
ffe
in
e
 Page 65 
selective both for caffeine and 5-CGA in the presence of a sodium caseinate 
matrix.   
Figure 4.10.  Sample chromatogram of 1:1 M ratio sodium caseinate:caffeine. 
Method correctly identified caffeine peak at RT = 21.5 min. 
 
Figure 4.11.  Sample chromatogram of 1:1 M ratio sodium caseinate:5-CGA. 
Note: peaks 3-CGA (RT ~13.3 min) and 4-CGA (RT ~24.5 min) are known 
degradation products of 5-CGA. Undetected peaks are labeled in parentheses at 
their retention times. Method correctly identified 5-CGA peak at RT = 15.5 min.  
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Figure 4.12.  Sodium caseinate matrix (sample blank) measured at 280 nm. 
Undetected peaks are labeled with parenthesis at their retention time. 
 
Figure 4.13.  Sodium caseinate matrix (sample blank) measured at 330 nm. 
Undetected peaks are labeled with parenthesis at their retention time. 
4.3 Experimental Design 
A Generalized Randomized Complete Block Design (GRCBD), blocked 
by day, was used as the design structure for these experiments. Blocked designs 
are used to control a nuisance factor; a known extraneous source of variation 
other than the treatment factors that affect the response. In these experiments, the 
day the experiments were performed was expected to have some effect on the 
response, therefore it was chosen as the random blocking factor. Complete block 
designs contain each treatment randomly assigned to at least one experimental 
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unit in each block, and do not have any replication within blocks. A GRCBD was 
employed because all samples were prepared in duplicate, therefore generalized 
RCBDs allow for replication within blocks. RCBDs reduce variability of 
treatment comparisons by allowing them to be made on more similar units with a 
block, thus ensuring more accurate results. The GRCBD model equation is shown 
in Equation 4.1.  
Equation 4.1 GRCBD model equation 
yijkl = µ + αi + βj + (αβ)ij +γk + εijkl 
Where:  yijkl = the quantitative response, concentration of bioactive 
compound at the ith and jth treatment levels, kth block and lth 
replicate  
µ = mean concentration of bioactive compound 
 
αi = main effect of the ith pH treatment level 
 
βj = main effect of the jth temperature treatment level 
 
(αβ)ij = interaction effect of the ith pH and jth temperature treatment 
levels 
γk = block effect from the kth block 
 
εijkl = random error term, we assume εijkl ~IN(0, σ2) 
A two-series 2k factorial design with k factor level combinations is often 
employed during screening experiments. Screening experiments attempt to 
identify which factors, out of k factors, significantly affect the response. 
Generally, levels of a factor are considered “low” and “high” to observe effects of 
the treatments on the response using extreme values in both directions. If the 
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objective of the investigator is to optimize treatment conditions that significantly 
affect the response, more experiments can be redesigned holding insignificant 
factors constant while varying significant factors at more levels. The model 
equation for a two-series 2k design is shown in Equation 4.2. For 2k designs, each 
model term has 1 degree of freedom (df). The df for treatment factors used in 
these experiments are shown in Table 4.2. 
Equation 4.2  Model equation for a two-series 2k factorial design 
yijk = µ + αi + βj + (αβ)ij + εijk 
Where: yijk = the quantitative response, concentration of bioactive 
compound at the ith  and jth treatment levels and kth replicate 
µ = mean concentration of bioactive compound 
αi = main effect of the ith pH treatment level 
βj = main effect of the jth temperature treatment level 
(αβ)ij = interaction effect of the ith pH and jth temperature treatment 
levels 
  εijk = random error term, we assume εijk ~IN(0, σ2) 
Table 4.2.  ANOVA table and df of treatment levels 
Source df 
pH 1 
Temperature 1 
pH*Temperature 1 
Block (day) 1 
Error 11 
Total 15 
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4.4 Binding caffeine & 5-CGA to sodium caseinate 
4.4.1 Binding caffeine to sodium caseinate trials 
To estimate the amount of binding that occurred between sodium caseinate 
and caffeine, a sample of the supernatant from each treatment combination was 
analyzed by RP-HPLC on the same day they were prepared. The concentration of 
caffeine recovered in the supernatant of each sample was calculated using a 
caffeine calibration curve, constructed prior to the sample analysis using a least 
squares regression line (Figure 4.14). The final caffeine concentration detected in 
the supernatant of each sample is shown in Figure 4.15. The concentration of 
caffeine was then converted to the percent of caffeine recovered from the known 
amount that was added to each sample, with the caffeine control sample 
containing 100% recovery of the added caffeine. The percentage of caffeine that 
was bound to sodium caseinate was then estimated based on the calculated 
difference between the initial amount of caffeine added and the amount of that 
was recovered in the supernatant. Therefore, the lesser amount of caffeine 
detected in the supernatant suggests more binding had occurred with the sodium 
caseinate.   
 Figure 4.14.  Caffeine calibration curve of peak area (mAU) vs. concentration 
(mg/mL). R2 = 0.9924.  
Figure 4.15.  Concentration of caffeine detected in the supernatant
prepared on Day 1 and Day 2. 
solution with no sodium caseinate.
sample. 
The concentration of caffeine detected in the supernatant of each sample 
was analyzed with an overall significance level at 
adjustment was performed to
decreasing the rate of Type 1 error and 
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 of all samples 
Caffeine control represents a caffeine standard 
 Error bars represent standard error of e
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ed in the samples (p = 0.5597). Since there was 
 > 0.01), interpretation of the main effects of pH 
effect on the true mean concentration 
 at 72 °C 
a calculated percentage of approximately 
(Figure 4.16). 
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than the effect of temperature at 25 °C on the mean caffeine concentration 
detected in the sample supernatant (Appendix B). The percent recovery of 
caffeine in samples prepared at 72 °C ranged between 65–80%, whereas samples 
prepared at 25 °C had a percent caffeine recovery ranging from 79–84%. 
Therefore, a calculated percentage of approximately 20–35% of the added 
caffeine was estimated to have been bound to sodium caseinate in samples 
prepared at 72 °C. This corresponds to a concentration of caffeine between 
0.0303–0.0523 mg/mL with a calculated average of 0.0413 mg/mL caffeine 
bound to sodium caseinate. This is compared to a calculated percentage of 
approximately 16–21% caffeine bound in samples prepared at 25 °C. This 
corresponds to a concentration of caffeine bound to sodium caseinate between 
0.0231–0.0319 mg/mL with a calculated average of 0.0275 mg/mL caffeine 
bound to sodium caseinate at 25 °C (Figure 4.17). Therefore, it was determined 
that 72 °C was the best of the two temperatures investigated that had a significant 
effect on the amount of caffeine recovered in the sample supernatant and thus also 
had a significant effect on the extent of binding between caffeine and sodium 
caseinate. The data was also analyzed for any violations of the ANOVA model 
assumptions (normality, equal variances). Because the experimental design was 
balanced, no violations of the model assumptions were detected (Appendix D).   
 Figure 4.17.  Calculated average concentration of caffeine bound to sodium 
caseinate at 25 °C and 72 °C
amount of caffeine bound to sodium caseinate at 100%.
Temperature was the only treatment that had a significant effect on the 
concentration of caffeine detected in the samples. The results from these 
experiments have also shown that optimal binding interactions between caffeine 
and sodium caseinate is tempera
resulting in greater binding. This suggests that the most likely mechanism for 
binding caffeine to sodium caseinate i
Hydrophobic interactions are highly temperature dependent, and be
not observed to have a significant effect on caffeine concentration, the binding 
mechanism was not likely due to electrostatic interactions. Therefore, 
conformational changes to the casein structure, such as denaturation of the protein 
at high temperatures, may increase binding sites available to caffeine.
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. Caffeine control represents the average theoretical 
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4.4.2 Binding 5-CGA to sodium caseinate trials 
The estimated amount of 5-CGA that was bound to sodium caseinate was 
measured in the same way as previously described with caffeine samples. A 
calibration curve of 5-CGA was also constructed prior to any sample analysis and 
used to calculate the concentration of 5-CGA detected in sample supernatants 
(Figure 4.18). The final 5-CGA concentration detected in the supernatant of each 
sample is shown in Figure 4.19.    
 
Figure 4.18.  5-CGA calibration curve of peak area (mAU) vs. concentration 
(mg/mL) at 330 nm. R2 = 0.9958. 
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samples (p = 0.0066). Though the main effect of temperature also had 
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effects should not be interpreted if interaction effects are significant. Therefore, 
the remainder of the statistical analysis will only focus on the interaction effect of 
pH and temperature. There was not enough evidence to conclude that the main 
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 of 5-CGA detected in the supernatant of all samples 
5-CGA control represents a 5-CGA standard 
 Error bars represent standard error of each 
αI = 0.0167, there was enough 
-CGA concentration detected in the supernatant of 
a 
-CGA concentration (p < 0.0001), main 
-CGA concentration
 (p = 0.2631).  
HSD) 
2
Day
5-CGA Control
pH 6.7 & 25 C rep 1
pH 6.7 & 25 C rep 2
pH 6.7 & 72 C rep 1
pH 6.7 & 72 C rep 2
pH 4.4 & 25 C rep 1
pH 4.4 & 25 C rep 2
pH 4.4 & 72 C rep 1
pH 4.4 & 72 C rep 2
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resulted in significantly different and increased binding interactions of 5-CGA to 
sodium caseinate (Appendix C). The treatment combinations pH 6.7 and 72 °C 
resulted in the lowest average 5-CGA concentration detected in the sample 
supernatant and was thus the best of the investigated conditions for binding 5-
CGA to sodium caseinate. The percentage of 5-CGA recovered in the sample 
supernatants at pH 6.7 and 72 °C ranged between 46–52%, therefore the 
calculated percentage of 5-CGA bound to sodium caseinate was estimated to be 
between 48–54% of the original amount of 5-CGA added. This corresponds to a 
calculated concentration of 5-CGA bound to sodium caseinate between 0.1159–
0.1311 mg/mL with a calculated average of 0.1235 mg/mL 5-CGA bound. 
Samples treated at pH 6.7 and 25 °C had a calculated concentration of 5-CGA 
bound to sodium caseinate that ranged between 0.0779–0.0903 mg/mL resulting 
in a calculated average of 0.0841 mg/mL 5-CGA bound (Figure 4.20). Compared 
to samples treated at pH 6.7 and 25 °C which resulted in a 5-CGA percent 
recovery ranging from 62–68%, the treatment conditions at pH 6.7 and 72 °C 
resulted in a calculated average increase of approximately 16.5%, or 
approximately 0.0437 mg/mL more 5-CGA bound to sodium caseinate. This data 
was also analyzed for any violations of the ANOVA model assumptions 
(normality, equal variances). Because the experimental design was balanced, no 
violations of the model assumptions were detected. (Appendix E).   
 Figure 4.20.  Calculated average concentration of 5
caseinate at 25 °C and 72 °C
average theoretical amount of 5
The results from these experiments show that the treatment combination of 
pH at 6.7 and temperature at 72 °C provided t
binding 5-CGA to sodium caseinate
that casein with a net negative charge at pH 6.7 and some extent of protein 
denaturation at 72 °C may increase binding sites available for 5
hydrophobic and electrostatic interactions are likely to be the mechanism of 
binding for 5-CGA to sodium caseinate as both pH and temperature had some 
influence on binding behavior.
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binding from a sample of green coffee extract that naturally contained both these 
compounds. The green coffee extract also contained numerous other unidentified 
compounds, thus this trial would demonstrate any interferences or competition of 
binding to sodium caseinate.  
Immediately upon addition of the green coffee extract to the sodium 
caseinate solution, the color of the solution turned from opaque white to dark 
gray-green. The color of the solution continued to develop while being stirred for 
1 h, turning into a dark emerald green color (Figure 4.21). During isoelectric 
precipitation with 0.1 N HCl, the sample solution returned to a bright white color 
and once the isoelectric point was reached (pH 4.6) the supernatant turned to a 
clear, light green color (Figure 4.22). The precipitated caseins contained a 
greenish hue in comparison to its usual bright white color. This indicated that 
some compounds responsible for the color of green coffee had been bound to 
sodium caseinate, possibly including 5-CGA as samples containing pure 5-CGA 
in previous studies resulted in a similar color change. Once the green coffee 
casein pellet was dried and compared to a control casein pellet, a noticeable green 
color remained in the green coffee pellet while no color change was observed in 
the control (Figure 4.23).  
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Figure 4.21.  Sodium caseinate solution before addition of green coffee extract 
(left) and after addition of green coffee extract (right). 
 
Figure 4.22.  Sample of sodium caseinate bound with green coffee extract after 
isoelectric precipitation at pH 4.6 and 30 °C.  
 Page 80 
 
Figure 4.23.  Casein pellets after centrifugation. Sodium caseinate control pellet 
(left) and sodium caseinate with green coffee extract pellet (right). 
The concentration of caffeine and 5-CGA detected in the supernatant of 
sodium caseinate with green coffee extract samples was comparable to results 
using commercial standards. Each sample was prepared in triplicate (Figure 4.24 
and Figure 4.25). The average percentage of caffeine bound to sodium caseinate 
was 16.51% (±0.04) corresponding to a calculated average concentration of 
0.1605 mg/mL caffeine bound from the total caffeine concentration of 0.9722 
mg/mL in the pure green coffee extract. The average percentage of CGA bound to 
sodium caseinate was 47.90% (±0.04), corresponding to a calculated average 
concentration of 2.098 mg/mL CGA bound from the total CGA concentration of 
4.379 mg/mL in the pure green coffee extract (Figure 4.26). These results 
confirmed the optimal binding conditions determined for each respective 
bioactive compound in previous studies using commercial standards. However, it 
is important to note that results from these experiments represent only an 
approximation, a calculated average concentration of the bioactive compound 
estimated to have been bound to sodium caseinate. Without direct measurement of 
 the casein pellet for the concentration of 
there is no way of definitively assessing the true concentration of the bound 
material.  
There appeared to be no detectable interfering compounds in the green 
coffee extract that inhibited binding of caffeine or 5
hydrophobic and electrostatic interactions is also likely to be the binding 
mechanism between caffeine and 5
extracts.  
 
Figure 4.24.  Concentration 
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bioactive compound actually bound, 
-CGA. A combination of 
-CGA to sodium caseinate from green coffee 
of caffeine detected in the supernatant of green 
. Error bars represent standard 
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Rep 3
 Figure 4.25.  Concentration of 5
extract with sodium caseinate samples.
each sample.  
Figure 4.26.  Calculated average concentration of caffeine and total CGA bound 
to sodium caseinate from green coffee extract at optimal treatment conditions pH 
6.7 & 72 °C. Controls represent the amount of bioactive compound detected in a 
pure green coffee extract sampl
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-CGA detected in the supernatant of green coffee 
 Error bars represent standard deviation of 
e.  
-CGA bound to sodium caseinate was 
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bioactive compound in a sample and the concentration recovered in the 
supernatant through HPLC analysis. A commercial standard of caffeine was 
injected and measured at 280 nm to determine the retention time of caffeine 
(Figure 4.27). Likewise, a commercial standard of 5-CGA was injected and 
measured at 330 nm to determine the retention time of 5-CGA (Figure 4.28). 
Green coffee extract samples contained CGA isomers with known retention times 
from previous studies. Retention times of all compounds are summarized in Table 
4.3.   
Figure 4.27.  Caffeine standard (1:16 dilution) measured at 280 nm. 
 
Figure 4.28.  CGA standard (1:16 dilution) measured at 330 nm. 
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Table 4.3.  Retention times and relative retention times of caffeine and CGA 
isomers  
Analyte Retention Time  (min) 
Relative Retention Time 
(min) 
Caffeine 21.4 1.000 
3-CGA 13.2 0.617 
4-CGA 23.2 1.080 
5-CGA 15.5 1.000 
3-FQA 29.4 1.900 
4-FQA 30.9 1.990 
5-FQA 34.7 2.240 
 
In sodium caseinate samples containing caffeine, a single caffeine peak was 
observed at approximately RT = 21.5 min, with no other impurity or degradation 
peaks observed in the chromatogram (Figure 4.29). In sodium caseinate samples 
containing 5-CGA, a large 5-CGA peak was observed at approximately RT = 15.5 
min, along with two minor peaks constituting 3-CGA (RT = 13.2 min) and 4-
CGA (RT = 23.2 min) that are likely due to degradation of CGA upon heating 
(Figure 4.30). It is important to note that degradation compounds were mostly 
observed in samples treated at 72 °C which is consistent with the behavior of 
CGAs upon heating.  
Figure 4.29.  Sample chromatogram of 1:1 M sodium caseinate:caffeine sample  
(pH 6.7, 72 °C). 
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Figure 4.30.  Sample chromatogram of 1:1 M sodium caseinate:5-CGA sample 
(pH 6.7, 72 °C). Unknown peak detected at RT ~ 9.5 min. Undetected peaks are 
labeled in parentheses. 
In green coffee extract samples, caffeine was observed at the expected RT, 
but the sample also contained many other peaks with a comparable peak height to 
caffeine that were not observed in the blank or sodium caseinate control and were 
thus not identified (Figure 4.31). These peaks were also not integrated nor used in 
the data analysis. 3-CGA, 4-CGA and 5-CGA isomers were observed in larger 
quantities in the green coffee extract samples with sodium caseinate. The peak 
areas of all CGA isomers were added together to quantify the total CGA 
concentration in samples. A sample of the pure green coffee extract with no 
sodium caseinate afforded all observable CGA isomers (Figure 4.32).  
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Figure 4.31.  Sodium caseinate and green coffee extract sample at 280nm  
(pH 6.7, 72 °C, rep 3). 
Figure 4.32.  Sample chromatogram of green coffee extract only measured at 330 
nm.  
4.6 BCA trials 
BCA trials were performed to confirm the absence of interference from 
soluble proteins remaining in the sample supernatant. The concentration of 
protein present in each sample was calculated using a standard curve of BSA, 
constructed prior to sample analysis (Figure 4.33). The absorbance of the blank 
solution was subtracted from the absorbance of each standard and sample to 
calculate the final protein concentration. The amount of protein from each sample 
ranged between 1–6% of the original sodium caseinate solution and was thus not 
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considered to be an interfering substance during caffeine or 5-CGA quantification 
(Table 4.4 and Table 4.5). In addition, a sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) analysis was run to qualitatively assess the 
amount of impurities (i.e. whey proteins) present in the original sodium caseinate 
powder used. The SDS-PAGE eletrophoretogram depicted in Figure 4.34 shows 
sodium caseinate with various dilutions that contained impurities present in the 
powder at relatively low intensities compared to sodium caseinate. This 
qualitative assessment showed any impurities or soluble proteins that remained in 
the supernatant after isoelectric precipitation of the caseins did not total to a 
significant amount and thus would not affect any interpretation of the data from 
these experiments.   
 
Figure 4.33.  BSA standard curve of absorbance at 562 nm vs. concentration 
(mg/mL). R2 = 0.9980. 
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Table 4.4.  BCA protein assay of 1:1 M sodium caseinate:caffeine samples 
Repetition pH Temperature ( °C) 
Concentration 
(mg/mL) 
Protein 
(%) 
1 6.7 25 0.2756 1.01 ± 0.00 
2 6.7 25 0.3018 1.11 ± 0.00 
1 6.7 72 0.3790 1.39 ± 0.00 
2 6.7 72 0.3671 1.35 ± 0.00 
1 4.4 25 0.2566 0.94 ± 0.00 
2 4.4 25 0.3077 1.13 ± 0.00 
1 4.4 72 0.3006 1.10 ± 0.00 
2 4.4 72 0.3434 1.26 ± 0.00 
 
Table 4.5.  BCA protein assay of 1:1 M sodium caseinate:5-CGA samples 
Repetition pH Temperature ( °C) 
Concentration 
(mg/mL) 
Protein 
(%) 
1 6.7 25 1.3120 4.82 ± 0.00 
2 6.7 25 1.2894 4.74 ± 0.00 
1 6.7 72 1.5319 5.63 ± 0.00 
2 6.7 72 1.5461 5.68 ± 0.00 
1 4.4 25 1.2133 4.46 ± 0.00 
2 4.4 25 1.2407 4.56 ± 0.00 
1 4.4 72 1.4035 5.16 ± 0.00 
2 4.4 72 1.4510 5.33 ± 0.00 
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Figure 4.34.  SDS-PAGE eletrophoretogram of sodium caseinate with various 
dilutions used in all experiments. Lane 1 = most dilute sample of sodium 
caseinate; lane 6 = least dilute sample of sodium caseinate. Impurities become 
less evident in diluted samples. The level of intensity of impurities in all lanes is 
markedly less than that of sodium caseinate. The far right lane depicts the 
molecular marker (ladder).    
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5.0 CONCLUSIONS 
Rates of coffee consumption worldwide continue to increase due to the 
uniquely satisfying flavor of coffee. Though most coffee consumers may not be 
aware of it, the bioactive compounds in coffee actually serve many important 
physiological functions in maintaining overall health. These benefits include 
hepatoprotective, hypoglycemic, and antiviral activity. Clearly, these health 
benefits warrant further investigation into exploiting their beneficial activities and 
imparting them from foods other than from coffee. Milk proteins have been 
remarkable at adapting to their evolutionary task of binding and transporting vital 
micronutrients from the mother to the neonate, thus the binding capacity of casein 
to caffeine and CGA and its use as a bioactive transport vehicle was the primary 
objective of this thesis. However, a procedure was first established to bind 
caffeine and CGA to sodium caseinate by determining the optimal chemical 
environment (pH and temperature) that would result in increased binding 
interactions based on the investigated treatment conditions. The steps in the 
developed procedure are both simple to carry out and relatively efficient thus 
providing a protocol that is neither time consuming nor labor intensive. The main 
effect of temperature was shown to have a significant effect on the concentration 
of caffeine detected in the supernatant and therefore the concentration that 
remained bound to sodium caseinate (p < 0.01). This suggests that binding of 
caffeine to sodium caseinate is likely via hydrophobic interactions. Conversely, 
the interaction effect of pH and temperature was shown to have a significant 
effect on the concentration of CGA detected in the supernatant and therefore the 
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concentration that remained bound to sodium caseinate (p < 0.01). This suggests 
the binding mechanism for CGA is likely a result of both electrostatic and 
hydrophobic interactions with sodium caseinate. The main effect of pH alone was 
not found to be statistically significant (p > 0.01) for either caffeine or CGA, 
indicating that electrostatic interactions alone are not likely to contribute to the 
binding mechanism. However, the main effect of pH may not have been 
statistically significant due to the fact that all samples were standardized to a final 
pH at 4.6 to precipitate the caseins. This may affect any reversible binding events 
that originally occurred at the initial investigated levels of pH. Essentially, the 
binding procedures provided herein may not have sufficiently shown the true 
effects of pH due to the inability to measure binding that occurred at the 
investigated levels of pH but rather, these procedures allowed only for binding 
measurements after isoelectric precipitation of the caseins, and therefore an 
estimated amount of binding that occurred at the final pH of 4.6.  
The difference in binding mechanisms between caffeine and 5-CGA to 
sodium caseinate could be attributed to the fundamental differences in their 
chemical structure. Compared to caffeine, 5-CGA contains a carboxylic acid  
(–COOH) functional group which can remain protonated or easily deprotonated 
by being in a chemical environment with a pH greater than its pKa (~3.5). 
Because the pKa of 5-CGA is relatively low, changes in its ionic state can be 
easily influenced by a smaller change in the pH of its chemical environment and 
thus influence binding with other molecules by electrostatic interactions. 
Conversely, the pKa of protonated amines are ~14 thus much larger changes to 
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the pH of its chemical environment are needed to influence electrostatic 
interactions. The small difference in electronegativity between the bonded atoms 
in the caffeine molecule makes it a relatively nonpolar compound. Thus it is 
plausible that caffeine binds to hydrophobic regions of the casein micelle once 
they have been exposed upon denaturation at higher temperatures. The prevalent 
binding mechanism between caffeine and the nonpolar regions of sodium 
caseinate are thus likely via hydrophobic interactions.    
Application of the optimal experimental conditions on a sample of green 
coffee extract which contained naturally occurring caffeine and CGA was 
performed to verify comparable binding capacity and reproducibility of the 
method as sodium caseinate with commercial standards of the bioactive 
compounds. Results from these experiments were in good agreement with the 
results from binding commercial standards of caffeine and 5-CGA to sodium 
caseinate. Simultaneous determination of caffeine and 5-CGA was achieved 
through the development, optimization, and validation of an analytical procedure 
by RP-HPLC. This method used common reagents that are readily accessible by 
most laboratories and provided a sensitive method for accurately quantifying both 
caffeine and CGA through demonstrating good results from validation studies that 
included: linearity, intra-assay precision, and selectivity.  
Results from these experiments provide but a modest contribution to the 
immense potential applications of coffee bioactive compounds in dairy products. 
Indeed, the procedures provided herein for binding caffeine and 5-CGA to sodium 
caseinate serves as a preliminary starting point for many more research endeavors 
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involving these health-promoting and versatile compounds. The continual 
development of sensitive analytical techniques for accurate quantification of 
molecules is needed by researchers across all disciplines of science, both in 
academia and industry. Thus through active collaboration of scientists from 
interdisciplinary backgrounds, such as those involved in this thesis work, insights 
into additional ways of incorporating the ever versatile casein micelle with other 
health promoting molecules is promising.        
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6.0 DIRECTIONS FOR FUTURE RESEARCH 
• Explore additional levels of the  main effects of pH and temperature to 
observe for possible trending in the extent of binding between caffeine and 
5-CGA with sodium caseinate 
• Hold insignificant factors constant while varying significant factors at 
larger ranges and employing a response surface model (RSM) to 
determine optimum treatment levels 
• Vary the molar ratio of coffee bioactive to sodium caseinate beyond a 1:1 
M ratio to observe any differences in the effects of using different 
concentrations of each compound  
• Investigate whether a specific fraction of casein is responsible for binding 
caffeine and 5-CGA by using commercial standards of α- and β-caseins 
• Direct measurement of the casein pellet for the amount of bound bioactive 
compound  
• Utilize additional characterization techniques such as dynamic light 
scattering (DLS) particle size analysis on changes to the casein micelle 
size and structure 
• Prepare heated samples using a stirring water bath to maintain better 
temperature control compared to using a hot plate 
• Study whether the same binding interactions occur with other bioactive 
compounds in coffee, such as caffeic acid 
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Appendix A: Data for precision studies on caffeine and 5-CGA 
 
 
  
Sample Name
Known Conc. 
(mg/mL)
Observed Conc. 
(mg/mL)
Peak Area
Average 
Peak Area
Relative Standard 
Deviation (% RSD)
Precision
Range
Caff A1 0.0625 0.071913 11,871,663    
Caff A2 0.0625 0.071901 11,869,737    
Caff A3 0.0625 0.071968 11,879,946    
Caff A4 0.0625 0.071936 11,875,076    
Caff A5 0.0625 0.071985 11,882,476    
Caff B1 0.03125 0.033021 6,002,144      
Caff B2 0.03125 0.033018 6,001,681      
Caff B3 0.03125 0.033010 6,000,485      
Caff B4 0.03125 0.032986 5,996,814      
Caff B5 0.03125 0.033027 6,003,092      
Caff C1 0.015625 0.013204 3,011,482      
Caff C2 0.015625 0.013207 3,011,870      
Caff C3 0.015625 0.013206 3,011,713      
Caff C4 0.015625 0.013229 3,015,277      
Caff C5 0.015625 0.013206 3,011,719      
<1%
<1%
<1%
     11,875,780 
        6,000,843 
        3,012,412 
0.05
0.04
0.05
Sample Name
Known Conc. 
(mg/mL)
Observed Conc. 
(mg/mL)
Peak Area
Average 
Peak Area
Relative Standard 
Deviation (% RSD)
Precision
Range
CGA A1 0.0625 0.065321 14,860,698    
CGA A2 0.0625 0.065782 14,978,295    
CGA A3 0.0625 0.065130 14,811,928    
CGA A4 0.0625 0.065207 14,831,589    
CGA A5 0.0625 0.064558 14,666,214    
CGA B1 0.03125 0.034415 6,978,188       
CGA B2 0.03125 0.034718 7,055,321       
CGA B3 0.03125 0.034776 7,070,062       
CGA B4 0.03125 0.034312 6,951,698       
CGA B5 0.03125 0.034431 6,982,247       
CGA C1 0.015625 0.019591 3,197,140       
CGA C2 0.015625 0.019706 3,226,576       
CGA C3 0.015625 0.019664 3,215,890       
CGA C4 0.015625 0.019403 3,149,330       
CGA C5 0.015625 0.019861 3,265,950       
<1%
<1%
1.33%
      14,829,745 
        7,007,503 
        3,210,977 
0.75
0.74
1.33
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Appendix B: Statistical analysis by JMP – binding caffeine to sodium 
caseinate trials 
 
 
Summary of Fit 
   
RSquare 0.611634 
RSquare Adj 0.514543 
Root Mean Square Error 0.00478 
Mean of Response 0.116781 
Observations (or Sum Wgts) 16 
 
Parameter Estimates 
Term   Estimate Std Error DFDen t Ratio Prob>|t| 
Intercept  0.1167813 0.000906 1 128.86 0.0049* 
pH[4.4]   -0.000156 0.001195 11  -0.13 0.8983 
Temperature[25]  0.0054562 0.001195 11 4.57 0.0008* 
pH[4.4]*Temperature[25]  0.0007187 0.001195 11 0.60 0.5597 
 
 
Fixed Effect Tests 
Source Nparm DF DFDen F Ratio Prob > F   
pH 1 1 11 0.0171 0.8983  
Temperature 1 1 11 20.8471 0.0008*  
pH*Temperature 1 1 11 0.3618 0.5597  
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pH 
Leverage Plot 
 
 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
4.4 0.11662500  0.00149978 
6.7 0.11693750  0.00149978 
 
LS Means Plot 
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LSMeans Differences Student's t 
α=0.017 
LSMean[i] By LSMean[j] 
Mean[i]-Mean[j] 
Std Err Dif 
Lower CL Dif 
Upper CL Dif 
4.4 6.7 
4.4 0 
0 
0 
0 
-0.0003 
0.00239 
-0.007 
0.00642 
6.7 0.00031 
0.00239 
-0.0064 
0.00705 
0 
0 
0 
0 
 
 
Level             Least Sq Mean 
6.7 A      0.11693750 
4.4 A      0.11662500 
 
Levels not connected by same letter are significantly different. 
 
Temperature 
Leverage Plot 
 
 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
25 0.12223750  0.00149978 
72 0.11132500  0.00149978 
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LS Means Plot 
 
LSMeans Differences Student's t 
α=0.017 
LSMean[i] By LSMean[j] 
Mean[i]-Mean[j] 
Std Err Dif 
Lower CL Dif 
Upper CL Dif 
25 72 
25 0 
0 
0 
0 
0.01091 
0.00239 
0.00418 
0.01765 
72 -0.0109 
0.00239 
-0.0176 
-0.0042 
0 
0 
0 
0 
 
Level             Least Sq Mean 
25 A       0.12223750 
72   B     0.11132500 
Levels not connected by same letter are significantly different. 
 
pH*Temperature 
Leverage Plot 
 
 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
4.4,25 0.12280000  0.00225952 
4.4,72 0.11045000  0.00225952 
6.7,25 0.12167500  0.00225952 
6.7,72 0.11220000  0.00225952 
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LS Means Plot 
 
pH*Temperature 
LSMeans Differences Tukey HSD 
α=0.017 
LSMean[i] By LSMean[j] 
Mean[i]-Mean[j] 
Std Err Dif 
Lower CL Dif 
Upper CL Dif 
4.4,25 4.4,72 6.7,25 6.7,72 
4.4,25 0 
0 
0 
0 
0.01235 
0.00338 
-4e-5 
0.02474 
0.00112 
0.00338 
-0.0113 
0.01351 
0.0106 
0.00338 
-0.0018 
0.02299 
4.4,72 -0.0123 
0.00338 
-0.0247 
0.00004 
0 
0 
0 
0 
-0.0112 
0.00338 
-0.0236 
0.00116 
-0.0018 
0.00338 
-0.0141 
0.01064 
6.7,25 -0.0011 
0.00338 
-0.0135 
0.01126 
0.01123 
0.00338 
-0.0012 
0.02361 
0 
0 
0 
0 
0.00947 
0.00338 
-0.0029 
0.02186 
6.7,72 -0.0106 
0.00338 
-0.023 
0.00179 
0.00175 
0.00338 
-0.0106 
0.01414 
-0.0095 
0.00338 
-0.0219 
0.00291 
0 
0 
0 
0 
 
Level             Least Sq Mean 
4.4,25 A      0.12280000 
6.7,25 A      0.12167500 
6.7,72 A      0.11220000 
4.4,72 A      0.11045000 
 
Levels not connected by same letter are significantly different. 
 
Day 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
1 0.11745078  0.00061075 
2 0.11611172  0.00061075 
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Interaction Profiles 
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Appendix C: Statistical analysis by JMP – binding 5-CGA to sodium 
caseinate trials 
 
 
Summary of Fit 
   
RSquare 0.812019 
RSquare Adj 0.765024 
Root Mean Square Error 0.008564 
Mean of Response 0.1374 
Observations (or Sum Wgts) 16 
 
Parameter Estimates 
Term   Estimate Std Error DFDen t Ratio Prob>|t| 
Intercept  0.1374 0.0014 1 98.14 0.0065* 
pH[4.4]   -0.002525 0.002141 11  -1.18 0.2631 
Temperature[25]  0.014675 0.002141 11 6.85 <.0001* 
pH[4.4]*Temperature[25]   -0.00715 0.002141 11  -3.34 0.0066* 
 
 
Fixed Effect Tests 
Source Nparm DF DFDen F Ratio Prob > F   
pH 1 1 11 1.3910 0.2631  
Temperature 1 1 11 46.9847 <.0001*  
pH*Temperature 1 1 11 11.1535 0.0066*  
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pH 
Leverage Plot 
 
 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
4.4 0.13487500  0.00255803 
6.7 0.13992500  0.00255803 
 
LS Means Plot 
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LSMeans Differences Student's t 
α=0.017 
LSMean[i] By LSMean[j] 
Mean[i]-Mean[j] 
Std Err Dif 
Lower CL Dif 
Upper CL Dif 
4.4 6.7 
4.4 0 
0 
0 
0 
-0.0051 
0.00428 
-0.0171 
0.00702 
6.7 0.00505 
0.00428 
-0.007 
0.01712 
0 
0 
0 
0 
 
Level             Least Sq Mean 
6.7 A      0.13992500 
4.4 A      0.13487500 
 
Levels not connected by same letter are significantly different. 
 
Temperature 
Leverage Plot 
 
 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
25 0.15207500  0.00255803 
72 0.12272500  0.00255803 
 
LS Means Plot 
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LSMeans Differences Student's t 
α=0.017 
LSMean[i] By LSMean[j] 
Mean[i]-Mean[j] 
Std Err Dif 
Lower CL Dif 
Upper CL Dif 
25 72 
25 0 
0 
0 
0 
0.02935 
0.00428 
0.01728 
0.04142 
72 -0.0294 
0.00428 
-0.0414 
-0.0173 
0 
0 
0 
0 
 
 
Level             Least Sq Mean 
25 A       0.15207500 
72   B     0.12272500 
 
Levels not connected by same letter are significantly different. 
 
pH*Temperature 
Leverage Plot 
 
 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
4.4,25 0.14240000  0.00396366 
4.4,72 0.12735000  0.00396366 
6.7,25 0.16175000  0.00396366 
6.7,72 0.11810000  0.00396366 
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LS Means Plot 
 
 
pH*Temperature 
LSMeans Differences Tukey HSD 
α=0.017 
LSMean[i] By LSMean[j] 
Mean[i]-Mean[j] 
Std Err Dif 
Lower CL Dif 
Upper CL Dif 
4.4,25 4.4,72 6.7,25 6.7,72 
4.4,25 0 
0 
0 
0 
0.01505 
0.00606 
-0.0071 
0.03725 
-0.0194 
0.00606 
-0.0415 
0.00285 
0.0243 
0.00606 
0.0021 
0.0465 
4.4,72 -0.0151 
0.00606 
-0.0372 
0.00715 
0 
0 
0 
0 
-0.0344 
0.00606 
-0.0566 
-0.0122 
0.00925 
0.00606 
-0.0129 
0.03145 
6.7,25 0.01935 
0.00606 
-0.0028 
0.04155 
0.0344 
0.00606 
0.0122 
0.0566 
0 
0 
0 
0 
0.04365 
0.00606 
0.02145 
0.06585 
6.7,72 -0.0243 
0.00606 
-0.0465 
-0.0021 
-0.0092 
0.00606 
-0.0314 
0.01295 
-0.0437 
0.00606 
-0.0658 
-0.0215 
0 
0 
0 
0 
 
 
Level             Least Sq Mean 
6.7,25 A        0.16175000 
4.4,25 A B      0.14240000 
4.4,72   B C    0.12735000 
6.7,72     C    0.11810000 
 
Levels not connected by same letter are significantly different. 
 
Day 
Least Squares Means Table 
Level Least Sq Mean   Std Error 
1 0.13552606  . 
2 0.13927394  . 
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Interaction Profiles 
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Appendix D: Statistical analysis by JMP – model assumptions (caffeine) 
Normality 
Distributions 
Studentized Resid Caffeine Conc. 
 
Normal(-4e-15,1.0328) 
 
Quantiles 
    
100.0% maximum 1.53725 
99.5%  1.53725 
97.5%  1.53725 
90.0%  1.24456 
75.0% quartile 0.51037 
50.0% median 0.17217 
25.0% quartile  -0.1706 
10.0%   -1.6688 
2.5%   -3.0376 
0.5%   -3.0376 
0.0% minimum  -3.0376 
 
Summary Statistics 
  
Mean  -4.08e-15 
Std Dev 1.0327956 
Std Err Mean 0.2581989 
Upper 95% Mean 0.5503379 
Lower 95% Mean  -0.550338 
N 16 
 
Fitted Normal 
Parameter Estimates 
Type Parameter Estimate Lower 95% Upper 95% 
Location µ  -4.08e-15  -0.550338 0.5503379 
Dispersion σ 1.0327956 0.7629311 1.5984486 
 
-2log(Likelihood) = 45.4386494007571 
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Equal Variances 
 
Residual by Predicted Plot 
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Appendix E: Statistical analysis by JMP – model assumptions (5-CGA) 
Normality 
Distributions 
Studentized Resid CGA Conc. 
 
Normal(1.1e-15,1.0328) 
 
Quantiles 
    
100.0% maximum 2.75655 
99.5%  2.75655 
97.5%  2.75655 
90.0%  1.73614 
75.0% quartile 0.47497 
50.0% median 0.02418 
25.0% quartile  -0.791 
10.0%   -1.2919 
2.5%   -1.4854 
0.5%   -1.4854 
0.0% minimum  -1.4854 
 
Summary Statistics 
   
Mean 1.055e-15 
Std Dev 1.0327956 
Std Err Mean 0.2581989 
Upper 95% Mean 0.5503379 
Lower 95% Mean  -0.550338 
N 16 
 
Fitted Normal 
Parameter Estimates 
Type Parameter Estimate Lower 95% Upper 95% 
Location Μ 1.055e-15  -0.550338 0.5503379 
Dispersion Σ 1.0327956 0.7629311 1.5984486 
 
-2log(Likelihood) = 45.4386494007507 
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Equal Variances 
Residual by Predicted Plot 
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